topic0
Study [mnob] 0.00840539693207
P NOS [aapp, imft] 0.00743681165543
Cardiovascular disease [dsyn] 0.00636267221859
treatment [ftcn] 0.00570075049028
Women [popg] 0.00512271608237
Methods [inpr] 0.00488758693619
Mortality [qnco] 0.00453879083596
CARDIOVASCULAR [bdsy] 0.00427025807322
Based [ftcn] 0.00421126398425
Group [idcn] 0.00416895173959
Increased [qnco] 0.00400377675817
Age [orga] 0.00373620168391
Trial [resa] 0.00370004999505
Compared [acty] 0.00362983896827
Conclusions [idcn] 0.00331585747484
treated [topp] 0.00324895991057
radiotherapy [inpr] 0.00308253243019
included [ftcn] 0.00303612170604
N NOS [aapp, imft] 0.00286258285114
therapy [ftcn] 0.00284981137475
effects [qlco] 0.00284718838326
Health [idcn] 0.00279594850646
Heart [bpoc] 0.00276770466822
Including [ftcn] 0.00274321903632
participants [popg] 0.00244577344574
Diabetes [dsyn] 0.00243691497803
Dose [qnco] 0.00230750926682
Care [acty] 0.00229952230432
Management [ocac] 0.00229364708116
months [tmco] 0.00223308856711
Cardiac [bpoc] 0.00223086679221
Efficacy [qlco] 0.00219566433403
Odds Ratio [qnco] 0.00216382091551
Quality [qlco] 0.00214489163815
Old [tmco] 0.00213811203461
Hypertension [dsyn] 0.00202858389522
Association [menp] 0.00201049741656
Heart failure [dsyn] 0.00188944827714
Suggest [idcn] 0.00185320792388
Range [qnco] 0.00184027787573
Specific [qlco] 0.0017891651961
Survival [acty] 0.00173315300121
Cases [ftcn] 0.00171999278956
Hazard Ratio [qnco] 0.00169414321438
Evaluated [ftcn] 0.00169178010123
Performed [ftcn] 0.00168776251527
Reported [inpr] 0.00167869272405
Reserve [acty] 0.00166479806241
Evaluate [ftcn] 0.00165875305642
Men [popg] 0.00164973909824
Observed [ftcn] 0.00163724993546
Assessed [acty] 0.00160316551712
Therapeutic [topp] 0.00158686695968
Surgery [bmod] 0.0015861350849
effective [qlco] 0.00154350279845
Need [qlco] 0.00154329050093
GY [geoa] 0.00154307909339
Benefit [qnco] 0.00154112362405
baseline [bodm] 0.00153956198616
placebo [topp] 0.00153373438635
Blood Pressure [orgf] 0.00153319631517
Stroke [dsyn] 0.00151798217461
Breast Cancer [neop] 0.00151249802957
High Risk [qlco] 0.00150369982698
intervention [hlca] 0.00150069254487
Adjusted [ftcn] 0.00149150481841
reduction [npop] 0.0014828223547
Identified [qlco] 0.00147806909658
Receive [qlco] 0.00146894608231
Complications [patf] 0.00146526595651
Subject [grup] 0.00145613150124
Current [tmco] 0.00144986771693
practice [menp] 0.00140005643026
Objective [inpr] 0.00139643376566
cardiovascular events [fndg] 0.00139441089847
condition [dsyn] 0.00139398662449
Target [ftcn] 0.0013748874788
Levels [qlco] 0.00135700664925
coronary artery disease [dsyn] 0.00135407471649
Myocardial Infarction [dsyn] 0.00134552875461
Approach [spco] 0.00133529050467
risk factors [qnco] 0.00133298852051
findings [ftcn] 0.00131183321906
Reduced [qlco] 0.0013065928009
IMPACT [gngm] 0.0013039848299
Medications [phsu] 0.00126824690989
Sclerotherapy [topp] 0.00126290947302
PREVENT [phsu] 0.00125943900107
Statin [orch, phsu] 0.00124956925777
Primary [qlco] 0.0012409172906
Improvement [cnce] 0.00123946634476
Prognostic Factor [clna] 0.00122763031127
Purpose [ftcn] 0.00122689582778
Induced [ftcn] 0.00122222564617
Life [idcn] 0.00121911745004
People [popg] 0.00121549305474
Needed [qlco] 0.00120038037111
coronary heart disease [dsyn] 0.00119766221797
Conduct [inbe] 0.00119207276121
Main [qlco] 0.00118706522247
Radiation [npop] 0.00118284854874
Design [acty] 0.00117730577021
Metabolic syndrome [dsyn] 0.00116443170407
Support [medd] 0.0011637288635
Present [qnco] 0.00115417216499
Independent [idcn] 0.00115217911809
Received [qlco] 0.00114862044534
interventions [hlca] 0.00113529200068
Drugs [phsu] 0.00113423951456
Available [ftcn] 0.00112573469062
postmenopausal [tmco] 0.00109933531914
Venous malformation [anab] 0.00108149559476
Select [acty] 0.0010732189283
Drug [phsu] 0.00106726939531
Statins [orch, phsu] 0.00106634868636
Affect [menp] 0.00105275250014
Comorbidities [idcn] 0.00105058495467
Increasing [ftcn] 0.00104706099866
Multiple [qnco] 0.00104420996436
Decreased [qnco] 0.00104178520231
Lipid [lipd] 0.00104141493405
Score [qnco] 0.00103983783895
Index [inpr] 0.00103562630791
Often [tmco] 0.00102290826478
objectives [inpr] 0.00102158264435
Following [tmco] 0.00101519576546
Atrial Fibrillation [patf] 0.00101306805811
Response [orga] 0.00101075927471
Young [tmco] 0.00100575445545
Appropriate [qlco] 0.00100536505191
Information [idcn] 0.00100143632443
Update [tmco] 0.00099807293044
Estimated [qnco] 0.000993852307974
Profile [lbpr] 0.000992893053815
Guidelines [inpr] 0.0009925818696
Aged [orga] 0.000987694106208
Functional [ftcn] 0.000983001139784
Five [qnco] 0.000981394073332
Evaluation [ftcn] 0.000979031850244
Controlled [ftcn] 0.00097843192209
Obesity [dsyn] 0.000970778625761
Safety [hcpp] 0.000966759115034
search [inpr] 0.000958802703973
vascular [bpoc] 0.000943980746094
Associations [menp] 0.000943309605031
Children [aggp] 0.000932698137121
Atherosclerosis [dsyn] 0.00093112160322
Comparison [acty] 0.000930409899874
strategies [menp] 0.00093024541428
Duration [tmco] 0.000929472382156
Published [ocac] 0.000918827704347
radiation therapy [inpr] 0.000911662483776
randomized [resa] 0.000910395509301
Survivors [podg] 0.000903010916223
Drug Therapy [topp] 0.00090157591283
considered [idcn] 0.000890993310048
Chemotherapy [topp] 0.000890130722702
Prostate Cancer [neop] 0.000887796030042
Article [inpr] 0.000883424543039
national [inpr] 0.000881629877083
symptoms [ftcn] 0.000880878781045
Long [qlco] 0.000880381632991
Aspirin [orch, phsu] 0.000869728128303
Acute Coronary Syndrome [dsyn] 0.000867092279667
criteria [inpr] 0.000866426723604
Oral [spco] 0.000865920388621
days [tmco] 0.000860352923779
Elderly [popg] 0.000860152940022
Exercise [dora] 0.000857778542026
Cardiovascular Diseases [dsyn] 0.000857579903939
Severe [qlco] 0.000857492353052
Limited [ftcn] 0.00085553043567
ischaemic heart disease [dsyn] 0.000852646565312
Recommended [idcn] 0.000845299807456
experience [menp] 0.000843718303066
Medication [phsu] 0.000843684563662
Help [socb] 0.00084309406431
Prevention [topp] 0.000841891408399
Defined [cnce] 0.000841828449053
Androgen Deprivation Therapy [topp] 0.00083308604415
Effectiveness [qlco] 0.00083287195343
Benefits [qnco] 0.00083006261666
Improved [qlco] 0.000828408582391
lesions [fndg] 0.00082651526027
Single [popg] 0.000824058558064
C-reactive protein [aapp, imft] 0.000823727572802
Make [ftcn] 0.000819394500183
society [orgt] 0.000810401433622
Menopause [phsf] 0.000800690212861
Large [qnco] 0.000799635330548
Adherence [ftcn] 0.000798320191466
Various [irda] 0.000792722229299
Events [evnt] 0.000792210503027
Cost Effectiveness [qnco] 0.000791855286216
Mechanisms [ftcn] 0.000791545914866
acute [tmco] 0.000788170078574
Literature [inpr] 0.000780555678717
Treatments [topp] 0.000774840821399
Smoking [inbe] 0.00077107768475
Medical [ftcn] 0.000765884963523
function [phsf] 0.000759426807373
LTD [ortf] 0.000755275349224
Hospitalization [hlca] 0.000754099713836
Hormone replacement therapy [topp] 0.000753238172733
Diseases [dsyn] 0.000750431575015
Known [qlco] 0.000749833477574
Knowledge [inpr] 0.000747433058469
Assessment [hlca] 0.000747242965666
Inspiration [orgf] 0.000744289291075
Average [qnco] 0.000742865901457
free [ftcn] 0.000741652840139
Complex [qlco] 0.000736583275636
strategy [menp] 0.000734215019815
Proportion [qnco] 0.000733141574783
Well [qlco] 0.000729586377702
System [ftcn] 0.000727187682412
Standard [qlco] 0.000726314337628
Authors [prog] 0.00071742774928
Combination [qlco] 0.000716666555785
Cardiology [bmod] 0.000715197525885
Cholesterol [bacs, strd] 0.00071157282829
patient care [hlca] 0.0007103521153
Irradiation [npop] 0.000710025744751
reviewed [inpr] 0.000709667826221
Local [spco] 0.000701648848143
Breast [bpoc] 0.000701134415503
Characteristics [qlco] 0.00069900558854
chronic [tmco] 0.000696925207581
GIVEN [cnce] 0.000696519865223
Hospital [hcro, mnob] 0.000692109078778
Discharge [bdsu] 0.000691696311677
Heart disease [dsyn] 0.000690647029751
Physical activity [dora] 0.000689728947657
Dyslipidaemia [dsyn] 0.000688957263112
Review, Systematic [inpr] 0.000686598473932
Take [hlca] 0.000686006025185
Congenital heart disease [cgab, dsyn] 0.00068189410093
prognostic [inpr] 0.000681578838065
Novel [tmco] 0.00067951710425
Imaging [diap] 0.00067917052174
Agent [chvf] 0.000678968851754
Flow [npop] 0.000677493351353
Decade [qnco] 0.000677148019794
Parameters [fndg] 0.000675403416332
variables [qlco] 0.000672325094309
Life Style [socb] 0.000662569665307
recommendations [idcn] 0.000661265560036
Primary Care [hlca] 0.000659356455263
investigate [ftcn] 0.000658974189828
Adult [aggp] 0.000658771210736
Female [fndg] 0.000657935195155
randomized controlled trials [inpr, resa] 0.000652569595026
Morbidity [qnco] 0.000651875035546
Searched [acty] 0.000650870052497
Six [qnco] 0.00064699571403
atorvastatin [orch, phsu] 0.000646259289218
Understanding [menp] 0.000645410248507
Values [qlco] 0.000642868866444
In [qnco] 0.000641481182856
Small [qnco] 0.000640916998848
Biomarkers [clna] 0.000640844106478
Several [qnco] 0.000640118773662
activity [dora] 0.000639250643163
Diagnosed [fndg] 0.000638533606388
Secondary Prevention [topp] 0.000637444324062
Future [tmco] 0.000637237410494
Strong [qlco] 0.00063621394339
Second [qnco] 0.000635442262907
Late [tmco] 0.000634773605503
Process [bpoc] 0.000633627719094
Measured [qlco] 0.000629452039045
deep breath [sosy] 0.000627778836736
Combined [qlco] 0.000626867577854
Center [spco] 0.000626754400938
Physicians [prog] 0.000626329792428
adverse events [fndg] 0.000625816104437
Confidence Intervals [qnco] 0.000624197056569
Relevant [qlco] 0.000623838906223
Alone [qnco] 0.000616124268231
Diabetes Mellitus [dsyn] 0.000615096956928
Obtained [ftcn] 0.000614097809893
weeks [tmco] 0.000613353708813
Risks [qlco] 0.000612583307
Decrease [qlco] 0.000611431996375
prescribed [hlca] 0.000609055228596
Tool [mnob] 0.000607685412042
Established [qlco] 0.000606980131923
Vascular Malformations [anab] 0.000606931829524
Ratio [qnco] 0.000606741258707
History [ocdi] 0.000606723209661
APPEAR [qlco] 0.000605125544861
Normal [qlco] 0.000604712753736
Database [inpr] 0.000603622129964
size [spco] 0.000602583868665
Program [cnce] 0.000601835085294
Sex [orgf] 0.000599971564238
Likely [qlco] 0.000597570445958
Issue [fndg] 0.000597297608506
Hold [idcn] 0.000596088383655
Additional [ftcn] 0.00059534973725
Report [inpr] 0.000591287967894
Bleeding [patf] 0.000589801988289
coronary [bpoc] 0.000589792866885
Estrogen [horm, phsu, strd] 0.000588557866261
Improving [qlco] 0.000585756418381
investigated [ftcn] 0.000583781446028
Acute myocardial infarction [dsyn] 0.000581944282217
side effects [ftcn] 0.000578851884355
Adults [aggp] 0.000575533967521
Eight [qnco] 0.000574908876848
Post [tmco] 0.000572258157562
American [popg] 0.000570715136149
Moderate [qlco] 0.000568127769454
mmHg [qnco] 0.000567767593169
High dose [qnco] 0.000567318407294
Surgical [hlca] 0.000566957703913
heart rate [clna] 0.000566414822354
Bias [idcn] 0.000563027294372
Therapies [topp] 0.00056026151721
Optimal [qlco] 0.000556895170927
Prescription [hlca] 0.000556852874524
Collected [idcn] 0.000556598189176
procedures [inpr] 0.000556511231159
Questionnaire [inpr] 0.000555992662372
Diet [food] 0.000552605947248
Leading [tmco] 0.000549051136954
setting [ftcn] 0.000547555172064
Body Mass Index [diap] 0.000545872063039
Area [geoa] 0.000545163662415
Symptomatic [ftcn] 0.000543487373136
Previous [tmco] 0.000543322121407
Out [spco] 0.000541463628214
Guide [prog] 0.000539881971413
Pulmonary arterial hypertension [dsyn] 0.000539426755836
Head [blor] 0.000538481040224
Relative [famg] 0.000534782218121
Meta-Analysis [inpr] 0.000534316942752
Clinical Trials [resa] 0.000532170647961
Relationship [qlco] 0.000531351913436
Reducing [qlco] 0.000530654496213
Pulmonary Hypertension [dsyn] 0.000530397689212
Required [ftcn] 0.000529759022545
Pulmonary Disease, Chronic Obstructive [dsyn] 0.000528864044774
???lead [elii, hops] 0.000528124121741
Cost [qnco] 0.000526615190294
Comprehensive [qlco] 0.000525541307579
Revealed [qlco] 0.000525236698466
Stage [tmco] 0.00052513001655
Systemic [ftcn] 0.000523980521317
Marker [clna] 0.00052279508936
Central [spco] 0.00052164633912
Examined [fndg] 0.000521577401104
Stable [qlco] 0.000521180210894
Models [inpr] 0.000517562789739
Complete [qlco] 0.000517233418267
atherosclerotic [ftcn] 0.000517098577424
Chronic kidney disease [dsyn] 0.000514291575094
Obese [dsyn] 0.000513893759311
Depression [mobd] 0.000513833719799
Address [inpr] 0.000513477732831
Doses [qnco] 0.000511126501398
majority [socb] 0.000509483277944
Polypharmacy [fndg] 0.000506070698413
Risk Ratio [qnco] 0.000505174181415
Occurred [acty] 0.000504927270299
Addition [ftcn] 0.000503385682455
left sided [spco] 0.000503121197591
Materials [sbst] 0.000501697169982
Best [qlco] 0.000501333977956
Order [inpr] 0.000500024777049
Concern [idcn] 0.000498767274244
mice [mamm] 0.000497173697874
Status [qlco] 0.000496600898391
Administration [ocac] 0.000496324877405
secondary [neop] 0.000495852379582
PLAN [dsyn] 0.000495450587911
Play [dora] 0.000495122145983
Plasma [bdsu] 0.000495016737979
Inflammation [patf] 0.000493194402915
Survey [inpr] 0.000492900666516
Interaction [ftcn] 0.000491679219049
cardiovascular risk factor [dsyn] 0.000490220829441
Calculated [ftcn] 0.000489575770766
lowering [spco] 0.000489407796314
Damage [inpo] 0.000488268685583
Region [geoa] 0.000488216455761
College [mnob] 0.000487242299263
Last [qlco] 0.000485532622879
prospective [resa] 0.000484218090606
Estrogens [horm, phsu, strd] 0.000483618701412
Currently [tmco] 0.000483566900817
Lung [bpoc] 0.000483471865196
Procedure [diap, topp] 0.000483190067884
paediatric [bmod] 0.000483003140908
Record [inpr] 0.000481225414696
Contribute [acty] 0.000478842572074
Recently [tmco] 0.000477363598752
Half [qnco] 0.000475477505511
Provided [acty] 0.000474115588597
Comorbidity [idcn] 0.000473773492329
topic1
P NOS [aapp, imft] 0.0121477875695
treatment [ftcn] 0.00801931735055
Group [idcn] 0.00634891127146
Women [popg] 0.00625868077632
Study [mnob] 0.0061330337788
Methods [inpr] 0.00547177223449
Cardiovascular disease [dsyn] 0.00530056028885
Age [orga] 0.0048696755205
Mortality [qnco] 0.00479908394919
Trial [resa] 0.00422472598783
Compared [acty] 0.00416843448107
Based [ftcn] 0.00382325614146
Increased [qnco] 0.00315202373474
CARDIOVASCULAR [bdsy] 0.00314564305902
Management [ocac] 0.00284489160915
Conclusions [idcn] 0.00280191397615
Hypertension [dsyn] 0.00272660526182
radiotherapy [inpr] 0.00269893065293
effects [qlco] 0.00249127860628
Diabetes [dsyn] 0.00247335801721
Efficacy [qlco] 0.0024605767475
participants [popg] 0.00244510272439
Including [ftcn] 0.00237073759745
Association [menp] 0.00236963891969
Men [popg] 0.00232229930326
N NOS [aapp, imft] 0.00227060281096
Heart [bpoc] 0.00224979032697
treated [topp] 0.00223763175073
risk factors [qnco] 0.0022129628448
therapy [ftcn] 0.0021837421924
Hazard Ratio [qnco] 0.0020806941187
Heart failure [dsyn] 0.00203587469657
Health [idcn] 0.00202160667438
included [ftcn] 0.00200574416678
months [tmco] 0.00195215138715
Care [acty] 0.00194198890461
Quality [qlco] 0.00187077827945
reduction [npop] 0.00180500334597
Specific [qlco] 0.00179496453262
intervention [hlca] 0.0017836045858
Present [qnco] 0.00173246862618
Dose [qnco] 0.0017313107299
Survival [acty] 0.00168904488255
Old [tmco] 0.001688643028
Cardiac [bpoc] 0.00166208056185
Stroke [dsyn] 0.00166173206786
Performed [ftcn] 0.00163753164238
Induced [ftcn] 0.00162073926081
condition [dsyn] 0.00161648367156
Children [aggp] 0.00161336314991
Cases [ftcn] 0.00161136139581
Reserve [acty] 0.00161128461892
IMPACT [gngm] 0.00159656485541
Primary [qlco] 0.00156155545349
Subject [grup] 0.00156064877621
Blood Pressure [orgf] 0.00153518414935
Suggest [idcn] 0.00153447178167
Current [tmco] 0.00150715581706
cardiovascular events [fndg] 0.00147807644344
Prevention [topp] 0.00147444810691
Breast Cancer [neop] 0.00147110400093
Objective [inpr] 0.00146414009311
Observed [ftcn] 0.00143065136134
Surgery [bmod] 0.00142670543441
Complications [patf] 0.00142364539312
Odds Ratio [qnco] 0.00140072204589
baseline [bodm] 0.00139867084188
Aged [orga] 0.00139242908684
High Risk [qlco] 0.00138965369031
Events [evnt] 0.00138539253843
Improvement [cnce] 0.00137599049802
Radiation [npop] 0.00132274407342
GY [geoa] 0.00131212901006
Received [qlco] 0.00130481760435
Life [idcn] 0.00130468182264
Identified [qlco] 0.00127768341879
coronary heart disease [dsyn] 0.00127293215137
Evaluated [ftcn] 0.00126585462739
Prognostic Factor [clna] 0.0012587731541
Approach [spco] 0.00125344544056
Published [ocac] 0.00124559751952
Assessed [acty] 0.00123302466583
Obesity [dsyn] 0.00122911817366
Myocardial Infarction [dsyn] 0.00122536727484
Limited [ftcn] 0.00122429159339
Evaluate [ftcn] 0.00122163290871
Increasing [ftcn] 0.0012204071553
Statins [orch, phsu] 0.00121106554302
Target [ftcn] 0.00120494640333
Design [acty] 0.00120350074658
Following [tmco] 0.00120288836779
Range [qnco] 0.00117139667021
Medications [phsu] 0.00116594138912
strategies [menp] 0.00116358954215
Main [qlco] 0.00115611521439
Benefit [qnco] 0.00115278847678
Sclerotherapy [topp] 0.00115237062915
Literature [inpr] 0.00114654181739
Evaluation [ftcn] 0.00114288313277
Reduced [qlco] 0.00114058250164
Reported [inpr] 0.00113928929332
Therapeutic [topp] 0.00113457104275
Safety [hcpp] 0.00113150983557
Several [qnco] 0.00112090663654
Guidelines [inpr] 0.00112032310545
experience [menp] 0.00112003646059
Drug [phsu] 0.00109952194668
Estimated [qnco] 0.00109535536556
Levels [qlco] 0.00107611782627
Comorbidities [idcn] 0.0010715299632
setting [ftcn] 0.00107070405373
Young [tmco] 0.00106791120434
placebo [topp] 0.00106328073719
Need [qlco] 0.00105060149629
objectives [inpr] 0.00103947280717
findings [ftcn] 0.00102899201973
considered [idcn] 0.00101615268939
Well [qlco] 0.00101496822701
Information [idcn] 0.00101484641608
interventions [hlca] 0.00101243465757
effective [qlco] 0.00100761164921
Severe [qlco] 0.00100685545339
Adjusted [ftcn] 0.00100342755237
Available [ftcn] 0.000997464758162
coronary artery disease [dsyn] 0.000996418149177
postmenopausal [tmco] 0.000994408172352
Combined [qlco] 0.000973653481804
PREVENT [phsu] 0.000972917255435
Decreased [qnco] 0.000961660946318
Effectiveness [qlco] 0.000959967620979
Receive [qlco] 0.000947603118666
Improved [qlco] 0.000943653054726
Long [qlco] 0.000942734911429
ischaemic heart disease [dsyn] 0.000939333596447
Morbidity [qnco] 0.000937543645822
Authors [prog] 0.00093702284783
Response [orga] 0.000935456393725
People [popg] 0.000935050405898
Heart disease [dsyn] 0.000930761381215
symptoms [ftcn] 0.000929588098298
Purpose [ftcn] 0.000927898918216
Diseases [dsyn] 0.000925970750335
Index [inpr] 0.000923480382425
Proportion [qnco] 0.00092158948979
Assessment [hlca] 0.000915338365614
Small [qnco] 0.000914712969104
Elderly [popg] 0.000912432517709
national [inpr] 0.000907901825402
Metabolic syndrome [dsyn] 0.000906822812002
Novel [tmco] 0.0009030776292
Recommended [idcn] 0.000900821633057
Measured [qlco] 0.000895623442591
practice [menp] 0.000881216389536
Conduct [inbe] 0.000879477533242
Confidence Intervals [qnco] 0.000873163910695
randomized [resa] 0.000871592717932
Report [inpr] 0.000871042353401
acute [tmco] 0.000868210930923
Smoking [inbe] 0.00086613829007
Irradiation [npop] 0.000864572632943
Congenital heart disease [cgab, dsyn] 0.000864517257329
Statin [orch, phsu] 0.000859345259055
free [ftcn] 0.000856733261165
Drugs [phsu] 0.00085420386076
Cardiovascular Diseases [dsyn] 0.000847459063416
Decrease [qlco] 0.000846758755634
Controlled [ftcn] 0.000842196062243
System [ftcn] 0.000841582158475
Single [popg] 0.00083955830113
Characteristics [qlco] 0.000836389025333
Stage [tmco] 0.000833220712865
Acute Coronary Syndrome [dsyn] 0.000830370469162
lesions [fndg] 0.000829998623164
Exercise [dora] 0.00082810410934
Comparison [acty] 0.000825865311807
Menopause [phsf] 0.000825007952737
Drug Therapy [topp] 0.000823897988976
reviewed [inpr] 0.000819206890366
Score [qnco] 0.000817877886716
Venous malformation [anab] 0.000814374489673
investigated [ftcn] 0.000814087910798
Support [medd] 0.000811554016891
Atherosclerosis [dsyn] 0.000809654937164
Medical [ftcn] 0.000809064577451
Multiple [qnco] 0.00080788891696
Medication [phsu] 0.000806158672066
Lipid [lipd] 0.000805641188577
mmHg [qnco] 0.000803333333821
Discharge [bdsu] 0.000802443047962
Reducing [qlco] 0.000801370652013
search [inpr] 0.000797522358108
Aspirin [orch, phsu] 0.000796098595188
Ageing [orgf] 0.000795853127138
Inflammatory [ftcn] 0.000793593307152
C-reactive protein [aapp, imft] 0.000793559115459
Needed [qlco] 0.000793308575889
Make [ftcn] 0.000788195120971
Often [tmco] 0.000787907090795
Hormone replacement therapy [topp] 0.000787761111293
Atrial Fibrillation [patf] 0.000787575246933
Combination [qlco] 0.000784575435096
Life Style [socb] 0.000782391787175
Complex [qlco] 0.000781767087163
Diagnosed [fndg] 0.000781375381446
Six [qnco] 0.000774800276465
Select [acty] 0.000770058426846
Relationship [qlco] 0.000763569952423
Burden [idcn] 0.000754260228069
Inspiration [orgf] 0.000754197840872
Sex [orgf] 0.000753623888989
function [phsf] 0.000750457309048
Future [tmco] 0.00074812215618
Diabetes Mellitus [dsyn] 0.000747499928122
days [tmco] 0.000745091861564
Likely [qlco] 0.000739822792151
Screening [hlca] 0.000737134906608
Known [qlco] 0.000735598835852
Profile [lbpr] 0.000730317944491
vascular [bpoc] 0.000725725482559
Help [socb] 0.000722505273174
Various [irda] 0.000715293419549
Adult [aggp] 0.000714329603753
Review, Systematic [inpr] 0.000712137567631
Estrogen [horm, phsu, strd] 0.000711798684136
Appropriate [qlco] 0.0007102012447
Primary Care [hlca] 0.000709952996218
Chemotherapy [topp] 0.000705485817261
secondary [neop] 0.000704163395197
Standard [qlco] 0.000702054339418
Adults [aggp] 0.00069953935487
radiation therapy [inpr] 0.000699381187255
Dyslipidaemia [dsyn] 0.000697377358774
Optimal [qlco] 0.000695623996526
Five [qnco] 0.000694739611024
Article [inpr] 0.000693922587973
Breast [bpoc] 0.000693897980974
Leading [tmco] 0.000689270765996
Cost Effectiveness [qnco] 0.000685297999092
Functional [ftcn] 0.000677470647888
criteria [inpr] 0.000677053161639
Meta-Analysis [inpr] 0.000676018970008
Treatments [topp] 0.00067437791632
Process [bpoc] 0.000674050499078
Defined [cnce] 0.000673815096788
Pulmonary Hypertension [dsyn] 0.000672882635932
In [qnco] 0.000671957755774
Address [inpr] 0.000668706128187
Large [qnco] 0.000668336177003
Prostate Cancer [neop] 0.0006678830164
Materials [sbst] 0.000666421016376
lack [qlco] 0.000662501712123
Mechanisms [ftcn] 0.000660125905299
society [orgt] 0.000659704084261
Understanding [menp] 0.000658136260564
???lead [elii, hops] 0.000656347119376
Survivors [podg] 0.000654433941545
Hold [idcn] 0.000654374728657
Program [cnce] 0.000651551780284
Parameters [fndg] 0.000648221125623
Oral [spco] 0.000647610205091
Cardiology [bmod] 0.000647209075157
Imaging [diap] 0.000645982815821
Examined [fndg] 0.000645872897785
Previous [tmco] 0.000644449616909
investigate [ftcn] 0.000642980585485
patient care [hlca] 0.000641920216317
Addition [ftcn] 0.000641251793117
weeks [tmco] 0.000639376690918
Searched [acty] 0.000638852234913
Doses [qnco] 0.000638154268702
heart rate [clna] 0.000635697654978
Hospitalization [hlca] 0.00063384822989
Androgen Deprivation Therapy [topp] 0.000630017896814
Marker [clna] 0.000629231819389
Average [qnco] 0.000628910002206
Best [qlco] 0.000627822979948
chronic [tmco] 0.000627441792754
Bleeding [patf] 0.00062644433175
Ischaemic [ftcn] 0.000626213664722
Agent [chvf] 0.0006225560843
Take [hlca] 0.000621629543758
Play [dora] 0.000618136541294
Moderate [qlco] 0.000615426589269
Late [tmco] 0.000612732892457
Update [tmco] 0.000607774230922
Independent [idcn] 0.000605614371868
Ischaemic stroke [dsyn] 0.000605571421576
Percutaneous Coronary Intervention [topp] 0.000604655109571
Point [qnco] 0.000601700013279
Magnetic Resonance Imaging [diap] 0.000596281802527
Adherence [ftcn] 0.000595919330572
Affect [menp] 0.000595141507326
Post [tmco] 0.000594155460738
Biomarkers [clna] 0.000593785593293
LTD [ortf] 0.000593501814975
Value [qnco] 0.000589981338289
Tool [mnob] 0.000589954176767
deaths [orgf] 0.000589480955067
Knowledge [inpr] 0.000588923384165
prescribed [hlca] 0.000587796304844
APPEAR [qlco] 0.000587718341922
Comprehensive [qlco] 0.000587142693105
Head [blor] 0.000586950628303
mice [mamm] 0.000586186940068
Issue [fndg] 0.0005858469754
Few [qnco] 0.000585376496453
recommendations [idcn] 0.000583860658692
Hospital [hcro, mnob] 0.000583020415165
Focus [spco] 0.000582691383705
Local [spco] 0.00058215642998
Second [qnco] 0.000579103681684
Advanced [qlco] 0.000579072338392
Established [qlco] 0.000577730044417
Diagnostic [fndg] 0.000577418632179
Interaction [ftcn] 0.000576437984246
History [ocdi] 0.000574414920825
Depression [mobd] 0.000574253191136
Survey [inpr] 0.000571575974919
Relevant [qlco] 0.000571548692831
Values [qlco] 0.000567455760931
Represent [acty] 0.000566815741754
Chronic kidney disease [dsyn] 0.000559520815315
paediatric [bmod] 0.000558531875426
Vascular Malformations [anab] 0.000558240357516
Consecutive [qlco] 0.000555892741268
American [popg] 0.000555706259651
Risks [qlco] 0.000554770329884
Damage [inpo] 0.000554643436041
strategy [menp] 0.000553433276906
Link [inpr] 0.000552787892868
Pulmonary arterial hypertension [dsyn] 0.000552353938198
High dose [qnco] 0.000549855353771
Fatal [qlco] 0.000544244231352
retrospective [resa] 0.000540848851292
Correlation [qlco] 0.000539459121486
Associations [menp] 0.00053646910198
prognostic [inpr] 0.000535014617617
Clinical Trials [resa] 0.000534974367182
Strong [qlco] 0.000534421031449
coronary [bpoc] 0.000533930794906
Obtained [ftcn] 0.000532419690966
Procedure [diap, topp] 0.000531265819303
Physical activity [dora] 0.000530923917968
adverse events [fndg] 0.000529290218142
prospective [resa] 0.00052847755903
Contribute [acty] 0.000526938395903
activity [dora] 0.000525140876349
Diet [food] 0.000524822838081
deep breath [sosy] 0.000522926113558
Hodgkin Lymphoma [neop] 0.000522500280243
GIVEN [cnce] 0.000522162228932
Lung [bpoc] 0.000522019824682
Symptomatic [ftcn] 0.000520840185769
Polypharmacy [fndg] 0.000518611466255
Metabolic [ftcn] 0.000518586595539
PLAN [dsyn] 0.000515687343879
Ratio [qnco] 0.00051358907871
Seven [qnco] 0.00051298194865
Improving [qlco] 0.000511800190347
size [spco] 0.000511574380365
Pre-operative [tmco] 0.000509740284905
Challenge [clna] 0.000509524276538
Complete [qlco] 0.000509105846816
Revealed [qlco] 0.000508353631812
Non-alcoholic Fatty Liver Disease [dsyn] 0.00050820868439
Estrogens [horm, phsu, strd] 0.000507720350161
Physicians [prog] 0.000506625415494
Plasma [bdsu] 0.000503610763291
Administration [ocac] 0.000501526213912
Advance [medd] 0.000500086448477
Postoperative [tmco] 0.000499698383751
Obese [dsyn] 0.000498291430023
High sensitivity [lbpr] 0.000498177058212
Female [fndg] 0.000497861901551
Exposure NOS [inpo] 0.000497696890249
Part [spco] 0.000497371509777
Applied [hlca] 0.000497002012006
Therapies [topp] 0.000496530737558
variables [qlco] 0.000494025550856
Currently [tmco] 0.000491950979177
left sided [spco] 0.000491345608426
mg% [qnco] 0.00049085794861
Global [spco] 0.000490147098252
Calculated [ftcn] 0.00048874684638
If [qlco] 0.000488590845692
Hormone Therapy [topp] 0.000488390772794
Relative [famg] 0.000487443921981
Occurred [acty] 0.000486432356735
Status [qlco] 0.000486344652368
side effects [ftcn] 0.000485484786371
Past [tmco] 0.000484021032744
Collected [idcn] 0.000482849100737
Regression [patf] 0.000480825830213
Additional [ftcn] 0.000478654654799
Gender [orga] 0.000477851196561
Systolic blood pressure [clna] 0.000475919567268
Atherosclerotic Cardiovascular Disease [dsyn] 0.000473824608194
Test [lbpr] 0.000473262260421
Died [orgf] 0.000472625827665
Chronic disease [dsyn] 0.000471203824221
topic2
treatment [ftcn] 0.0135790641118
P NOS [aapp, imft] 0.0102122745411
Study [mnob] 0.00609615807201
Mortality [qnco] 0.00579269024557
Women [popg] 0.00559336325401
Cardiovascular disease [dsyn] 0.00524095222047
Age [orga] 0.00521731751545
Compared [acty] 0.00520780523992
Group [idcn] 0.00492909509031
Methods [inpr] 0.00459984009927
CARDIOVASCULAR [bdsy] 0.00433968999911
radiotherapy [inpr] 0.0031247550605
Increased [qnco] 0.00308991770007
Hypertension [dsyn] 0.00307678650321
Based [ftcn] 0.00301194189969
Heart [bpoc] 0.00299783571282
Trial [resa] 0.00291322986261
effects [qlco] 0.0025564409419
Management [ocac] 0.00252335791021
therapy [ftcn] 0.00248489294661
participants [popg] 0.00242523219507
Old [tmco] 0.0022948461992
N NOS [aapp, imft] 0.00226614797806
Conclusions [idcn] 0.00223059722687
Quality [qlco] 0.00222342261087
Dose [qnco] 0.00218793249147
Health [idcn] 0.00213984166175
included [ftcn] 0.00211278941052
Survival [acty] 0.00205791867374
Cardiac [bpoc] 0.00204219180474
treated [topp] 0.00200642955137
Including [ftcn] 0.00199056769833
Present [qnco] 0.00197946047078
Levels [qlco] 0.00196166393119
baseline [bodm] 0.00190906251688
Diabetes [dsyn] 0.00189418518192
Surgery [bmod] 0.00182535485463
Specific [qlco] 0.00182221677851
Target [ftcn] 0.00181713166158
Suggest [idcn] 0.00181656149852
Hazard Ratio [qnco] 0.00178768442173
Evaluated [ftcn] 0.00178534594159
Stroke [dsyn] 0.0017643295566
Efficacy [qlco] 0.00175207316002
High Risk [qlco] 0.00173424375385
Evaluate [ftcn] 0.00171901126757
months [tmco] 0.00171536219999
Reported [inpr] 0.00168243835906
Association [menp] 0.00167515148878
IMPACT [gngm] 0.00166326201588
risk factors [qnco] 0.00165228123816
cardiovascular events [fndg] 0.0016241409361
effective [qlco] 0.00162355240062
reduction [npop] 0.00161738000159
Care [acty] 0.001615753588
Children [aggp] 0.00161355209344
Cases [ftcn] 0.0015970054299
Reduced [qlco] 0.00153529590216
Prevention [topp] 0.00151790556542
Sclerotherapy [topp] 0.00151359717973
Received [qlco] 0.00149388057473
Men [popg] 0.00147143051067
strategies [menp] 0.00145035313898
intervention [hlca] 0.00143354274506
coronary heart disease [dsyn] 0.00140896580103
Performed [ftcn] 0.0013895477774
Purpose [ftcn] 0.00138461991114
Receive [qlco] 0.001380741291
Life [idcn] 0.00137233582688
Breast Cancer [neop] 0.00135586688462
Estimated [qnco] 0.00134624073551
Guidelines [inpr] 0.00133414674536
Assessed [acty] 0.00132661063037
Radiation [npop] 0.00132461068821
Improved [qlco] 0.00132195503987
Statin [orch, phsu] 0.00129995433761
Reserve [acty] 0.0012923828806
Following [tmco] 0.0012877648567
Decreased [qnco] 0.00128648978118
Complications [patf] 0.00127173679089
Subject [grup] 0.00127019516931
Identified [qlco] 0.00126789872547
Available [ftcn] 0.00125802818964
Heart failure [dsyn] 0.00125636031635
Venous malformation [anab] 0.00125147843335
Objective [inpr] 0.00124867072513
GY [geoa] 0.0012449806363
Medications [phsu] 0.00124290653956
Drugs [phsu] 0.00122485973522
Decrease [qlco] 0.00121778124747
Benefit [qnco] 0.00121716813781
Information [idcn] 0.00120769161817
Aged [orga] 0.00120291819488
Approach [spco] 0.00119970880311
Induced [ftcn] 0.00119813166596
Blood Pressure [orgf] 0.00119417024958
Make [ftcn] 0.00117809570852
Conduct [inbe] 0.00116124578914
Observed [ftcn] 0.00116006726707
Appropriate [qlco] 0.00115957378104
Odds Ratio [qnco] 0.00115710298529
Medical [ftcn] 0.00114509775003
national [inpr] 0.00114125221565
Irradiation [npop] 0.00112851782895
Therapeutic [topp] 0.00112173359707
Need [qlco] 0.0011131052897
Safety [hcpp] 0.0011110445874
Prognostic Factor [clna] 0.00110557938638
Improvement [cnce] 0.00110221862083
placebo [topp] 0.00110074286578
Design [acty] 0.00108540320075
search [inpr] 0.00108285930578
Myocardial Infarction [dsyn] 0.00107426557262
Primary [qlco] 0.00106432588767
Treatments [topp] 0.00106323462575
Hormone replacement therapy [topp] 0.00105085661767
People [popg] 0.00104813154389
Support [medd] 0.0010430469289
Events [evnt] 0.00103689124673
objectives [inpr] 0.00103667587326
Effectiveness [qlco] 0.00103430346518
Future [tmco] 0.00103222034938
Measured [qlco] 0.00103001120077
Published [ocac] 0.00102929089424
days [tmco] 0.00102652333211
interventions [hlca] 0.00102260676013
Atrial Fibrillation [patf] 0.00101575768633
Needed [qlco] 0.00101120754099
Current [tmco] 0.00100800398873
condition [dsyn] 0.0010070398286
Range [qnco] 0.000985206416258
Heart disease [dsyn] 0.000978424047261
practice [menp] 0.000978022272893
Adjusted [ftcn] 0.000965658849597
Drug Therapy [topp] 0.000960340274496
Diseases [dsyn] 0.000955477857784
Independent [idcn] 0.000954046832926
Limited [ftcn] 0.000951337557366
findings [ftcn] 0.000946443988729
Metabolic syndrome [dsyn] 0.000943985938014
Severe [qlco] 0.000930635442926
PREVENT [phsu] 0.000918295509342
Controlled [ftcn] 0.000914298489765
Statins [orch, phsu] 0.000913435552161
Hospital [hcro, mnob] 0.000913071276505
vascular [bpoc] 0.000910876429243
Evaluation [ftcn] 0.000908748686843
Update [tmco] 0.000906028237407
Index [inpr] 0.000905886836516
Score [qnco] 0.000904295203795
postmenopausal [tmco] 0.00090295734336
Literature [inpr] 0.000887477883156
setting [ftcn] 0.000887319604577
Article [inpr] 0.000885502311287
coronary artery disease [dsyn] 0.00088543065434
Combined [qlco] 0.00088334789293
Lipid [lipd] 0.000876494596964
Relationship [qlco] 0.000876220920291
Long [qlco] 0.000868828579226
Breast [bpoc] 0.000868722992351
radiation therapy [inpr] 0.000865981653943
Average [qnco] 0.000862485440889
randomized [resa] 0.000862335051587
Profile [lbpr] 0.000857746279053
Medication [phsu] 0.000857639440842
experience [menp] 0.000851508534466
Sex [orgf] 0.000849610354161
ischaemic heart disease [dsyn] 0.000849446697939
Assessment [hlca] 0.000849281102982
Mechanisms [ftcn] 0.000843046858058
Atherosclerosis [dsyn] 0.000839367695259
free [ftcn] 0.000839163871898
GIVEN [cnce] 0.000839148369932
Complex [qlco] 0.000837637012771
Single [popg] 0.000828375841202
Several [qnco] 0.000826783994831
Chemotherapy [topp] 0.00081668528265
Relevant [qlco] 0.000811989481357
Various [irda] 0.000811835058544
Associations [menp] 0.000805816539984
Small [qnco] 0.000804179104609
Often [tmco] 0.000800887657109
Young [tmco] 0.000793506421735
Drug [phsu] 0.000791450070565
Defined [cnce] 0.000790078097178
Exercise [dora] 0.000786801558837
Main [qlco] 0.000785774324101
Morbidity [qnco] 0.000784930883402
Adults [aggp] 0.000783076784582
Authors [prog] 0.00077790191922
Survivors [podg] 0.000776766626233
Aspirin [orch, phsu] 0.000776676353316
Multiple [qnco] 0.000775514051731
Characteristics [qlco] 0.000773958068372
Menopause [phsf] 0.000770221365961
Cardiology [bmod] 0.000769892510328
Likely [qlco] 0.000767704514697
Take [hlca] 0.000766145165838
Searched [acty] 0.000763556775139
reviewed [inpr] 0.000763094693975
Smoking [inbe] 0.000759302858238
Parameters [fndg] 0.000755671717311
Diet [food] 0.000754933525128
Increasing [ftcn] 0.000754540330597
System [ftcn] 0.000752898086984
Comparison [acty] 0.000751534146431
Combination [qlco] 0.000748719248909
Models [inpr] 0.000742187371036
acute [tmco] 0.000741959981224
left sided [spco] 0.000740046893132
Cost Effectiveness [qnco] 0.000739168522816
lesions [fndg] 0.000738190371497
Hold [idcn] 0.000737137706008
Large [qnco] 0.000736354377222
criteria [inpr] 0.000730387756185
Comorbidities [idcn] 0.000728966627549
Elderly [popg] 0.000727911152885
Test [lbpr] 0.000726222146898
function [phsf] 0.000725876852413
Regression [patf] 0.000723874573708
symptoms [ftcn] 0.000721856043279
Pulmonary Hypertension [dsyn] 0.000721545948214
Inspiration [orgf] 0.000719147107482
Affect [menp] 0.000714819347487
Life Style [socb] 0.000714635647584
Surgical [hlca] 0.000714002252084
Understanding [menp] 0.000713457273083
Burden [idcn] 0.000704005149525
Novel [tmco] 0.00070350917283
Screening [hlca] 0.000700039500813
Proportion [qnco] 0.000698884250583
Confidence Intervals [qnco] 0.000695616663878
Diagnosed [fndg] 0.000695197638221
Collected [idcn] 0.000695119107263
Revealed [qlco] 0.000690964013826
International [idcn] 0.0006906584201
Work [ocac] 0.000689286501967
Known [qlco] 0.000684940665845
Cardiovascular Diseases [dsyn] 0.000683238673812
Established [qlco] 0.000683156439244
Examined [fndg] 0.000675949592812
Functional [ftcn] 0.000675712709887
recommendations [idcn] 0.000671256893789
History [ocdi] 0.00066960606507
Address [inpr] 0.000668146673421
activity [dora] 0.00066637763389
Imaging [diap] 0.000661016734403
Plasma [bdsu] 0.00065881303341
Therapies [topp] 0.000655261035306
mmHg [qnco] 0.000654509836142
patient care [hlca] 0.000653477441421
Process [bpoc] 0.000652312633358
C-reactive protein [aapp, imft] 0.000647373029142
Leading [tmco] 0.00064363931762
Obesity [dsyn] 0.000640538756737
Obtained [ftcn] 0.000636552735664
Physicians [prog] 0.000636391725312
In [qnco] 0.000636088261058
Meta-Analysis [inpr] 0.000635981434317
Bleeding [patf] 0.0006348964672
Acute Coronary Syndrome [dsyn] 0.00063224941815
Physical activity [dora] 0.000631758898068
Addition [ftcn] 0.000630280493943
Benefits [qnco] 0.000630190257654
Issue [fndg] 0.000627864868155
Moderate [qlco] 0.000625722400834
society [orgt] 0.000624467234817
Response [orga] 0.000622892578965
Occurred [acty] 0.000620013672107
Late [tmco] 0.00061951436651
prospective [resa] 0.000616715489055
Play [dora] 0.000615837614981
side effects [ftcn] 0.000614446938651
Discharge [bdsu] 0.000614258182105
???lead [elii, hops] 0.000609774518004
Select [acty] 0.000609377937176
Depression [mobd] 0.0006063400956
Adult [aggp] 0.000604900570857
deep breath [sosy] 0.000601383546023
Congenital heart disease [cgab, dsyn] 0.000600830101229
lowering [spco] 0.00059910841898
Body Mass Index [diap] 0.000597839565277
considered [idcn] 0.000593743028481
investigate [ftcn] 0.000592805526557
heart rate [clna] 0.000591205499602
Ratio [qnco] 0.00059080084822
Challenge [clna] 0.000588715358331
Stage [tmco] 0.000588499448717
strategy [menp] 0.000588465063679
Local [spco] 0.000588027579959
Exposure NOS [inpo] 0.000584269409332
Postoperative [tmco] 0.000583569966725
Ageing [orgf] 0.000582950957487
Prostate Cancer [neop] 0.000582280156667
Additional [ftcn] 0.000580855181454
Biomarkers [clna] 0.000579869804235
Advanced [qlco] 0.000579861833717
paediatric [bmod] 0.000579166712081
Female [fndg] 0.000579038498866
cardiovascular risk factor [dsyn] 0.000576584309969
Agent [chvf] 0.00057648223281
Improving [qlco] 0.000574010794763
Primary Care [hlca] 0.00057304324226
Chronic kidney disease [dsyn] 0.000571912303661
variables [qlco] 0.000571632276176
Percutaneous Coronary Intervention [topp] 0.000567785403875
Reducing [qlco] 0.000566356855514
Flow [npop] 0.000566324686278
Recommended [idcn] 0.000564959968343
Review, Systematic [inpr] 0.00056299791501
Values [qlco] 0.000562583319322
Area [geoa] 0.000562580344436
Alone [qnco] 0.000558627232988
Well [qlco] 0.000558472818683
Materials [sbst] 0.000557107583162
Relative [famg] 0.000556349017597
Oral [spco] 0.000555692661912
Risks [qlco] 0.00055541982587
Magnetic Resonance Imaging [diap] 0.00055496945645
Last [qlco] 0.000554089054881
Best [qlco] 0.000553814226069
randomized controlled trials [inpr, resa] 0.000552592209924
APPEAR [qlco] 0.000551510252571
Few [qnco] 0.000550896157493
Tool [mnob] 0.000549507552986
Knowledge [inpr] 0.000549283362634
Procedure [diap, topp] 0.000548228213334
Polypharmacy [fndg] 0.000548013973835
Symptomatic [ftcn] 0.000547908547412
investigated [ftcn] 0.000546886923469
size [spco] 0.000546296255401
Doses [qnco] 0.000545433565134
Sample [sbst] 0.000545229065438
Diagnostic [fndg] 0.000545034175142
Correlation [qlco] 0.000544074326882
prognostic [inpr] 0.000543667688771
Database [inpr] 0.000543185506761
atherosclerotic [ftcn] 0.000542152231926
Duration [tmco] 0.000539978741446
Approaches [spco] 0.000539364505526
Status [qlco] 0.00053710949997
Clinical Trials [resa] 0.000533998654182
Bias [idcn] 0.000531218463065
Cholesterol [bacs, strd] 0.000529996478329
Vascular Malformations [anab] 0.00052983090478
Onset [qlco] 0.00052510419103
adverse events [fndg] 0.000524893363433
Estrogen [horm, phsu, strd] 0.000524761200378
Program [cnce] 0.000524625074017
Marker [clna] 0.000523958858731
Previous [tmco] 0.000522652642026
Dyslipidaemia [dsyn] 0.000521716909925
Systemic [ftcn] 0.000521026182426
retrospective [resa] 0.000520429205631
chronic [tmco] 0.000520283031683
mice [mamm] 0.000516808721502
Report [inpr] 0.0005153653602
secondary [neop] 0.000512847372642
Represent [acty] 0.000512173870409
Non-alcoholic Fatty Liver Disease [dsyn] 0.00051187483752
Hospitalization [hlca] 0.000511771100146
Age-Years [tmco] 0.000511633795536
coronary [bpoc] 0.000510795643875
Radiotherapy, Intensity-Modulated [topp] 0.00050910693293
Part [spco] 0.000507228686187
Same [qlco] 0.000506941585188
Ischaemic [ftcn] 0.000503198274394
Cost [qnco] 0.00050181010838
Advance [medd] 0.00050152452036
Global [spco] 0.000500644415269
Decade [qnco] 0.000498406701651
Eight [qnco] 0.000496894965406
lack [qlco] 0.000496817558295
Guide [prog] 0.000495996958056
Damage [inpo] 0.00049487378569
Gender [orga] 0.000493425559848
Center [spco] 0.000492692181342
Arterial [bpoc] 0.000492533534716
Point [qnco] 0.00049131212588
procedures [inpr] 0.00049066374361
Estrogens [horm, phsu, strd] 0.000490625716643
Good [qlco] 0.000488211716478
subgroup [virs] 0.000487398215719
Five [qnco] 0.000486985951368
Paper [mnob] 0.000485944875388
VALVE [medd] 0.000484976681428
Measure [qnco] 0.000484563614582
Contribute [acty] 0.000484544733759
Length [qnco] 0.000484475552899
Risk Ratio [qnco] 0.000483122269429
Venous Thromboembolism [patf] 0.000483035363745
Central [spco] 0.000481685703437
Fatal [qlco] 0.000479454224027
End [spco] 0.000478209119478
Inflammatory [ftcn] 0.000477975615929
Multi [qnco] 0.000477115035898
Secondary Prevention [topp] 0.000476554989509
prescribed [hlca] 0.000474409509828
Inflammation [patf] 0.000474171906087
Interaction [ftcn] 0.000473293956066
topic3
treatment [ftcn] 0.0117036466268
P NOS [aapp, imft] 0.011609242822
Study [mnob] 0.00779318880452
Group [idcn] 0.00582505575008
Trial [resa] 0.00501524182639
Women [popg] 0.00434247333598
Methods [inpr] 0.00433712971367
Age [orga] 0.00413838156772
Mortality [qnco] 0.00402119786088
Cardiovascular disease [dsyn] 0.00383664935731
CARDIOVASCULAR [bdsy] 0.00379415816095
Based [ftcn] 0.00375280419285
Compared [acty] 0.00363623252995
Increased [qnco] 0.00313058063434
radiotherapy [inpr] 0.00283600820779
included [ftcn] 0.00274351143839
Management [ocac] 0.00273910752549
Association [menp] 0.00268789590355
Conclusions [idcn] 0.00264752488407
Hypertension [dsyn] 0.00262564715338
Diabetes [dsyn] 0.0025944461312
N NOS [aapp, imft] 0.00259205596419
Cardiac [bpoc] 0.00256549173023
effects [qlco] 0.00253438749202
Including [ftcn] 0.00225873240064
therapy [ftcn] 0.00218278147621
participants [popg] 0.00214759189302
treated [topp] 0.00210087872059
Heart failure [dsyn] 0.00205784130297
Survival [acty] 0.00201303868095
Stroke [dsyn] 0.00195271030376
Reduced [qlco] 0.00194708188813
Health [idcn] 0.00193142049072
Dose [qnco] 0.00191696921449
risk factors [qnco] 0.00190795709659
Hazard Ratio [qnco] 0.00190597936422
Heart [bpoc] 0.00189334265379
Breast Cancer [neop] 0.00188263143528
Efficacy [qlco] 0.0018468368594
Blood Pressure [orgf] 0.00180339376666
effective [qlco] 0.001791784565
Specific [qlco] 0.00177070876864
months [tmco] 0.00176756094767
Odds Ratio [qnco] 0.00173685924204
Observed [ftcn] 0.00170416318331
Reserve [acty] 0.00170177303962
Objective [inpr] 0.00169820773159
GY [geoa] 0.00169730884155
condition [dsyn] 0.00168712992464
Present [qnco] 0.00167827312568
Evaluate [ftcn] 0.00163855453556
Guidelines [inpr] 0.00162380824298
Cases [ftcn] 0.00161828362577
IMPACT [gngm] 0.00159752552905
Quality [qlco] 0.00159039633611
Reported [inpr] 0.00156508761418
Performed [ftcn] 0.00153178287227
Prognostic Factor [clna] 0.00152521175338
Suggest [idcn] 0.00152106774835
Statin [orch, phsu] 0.00150734642386
Complications [patf] 0.00150593166828
Identified [qlco] 0.0014879346073
Men [popg] 0.00147353629793
Care [acty] 0.00142887296461
Surgery [bmod] 0.00141783319031
Levels [qlco] 0.00138513643982
Response [orga] 0.00138121781954
coronary heart disease [dsyn] 0.00137388443753
Old [tmco] 0.00137298253907
Approach [spco] 0.0013495438365
High Risk [qlco] 0.00134648689042
Need [qlco] 0.00131939664431
Subject [grup] 0.00130740200411
Received [qlco] 0.00130038057097
Radiation [npop] 0.00129077662353
Primary [qlco] 0.0012854338329
Controlled [ftcn] 0.00127968131667
Events [evnt] 0.00127834524375
Sclerotherapy [topp] 0.00127093071117
baseline [bodm] 0.00125158937611
Life [idcn] 0.00124107451018
Estimated [qnco] 0.00122069613545
Prevention [topp] 0.00121451584532
Statins [orch, phsu] 0.00121177126821
Myocardial Infarction [dsyn] 0.00120524551221
Receive [qlco] 0.00120170287413
Venous malformation [anab] 0.00118527367632
strategies [menp] 0.00117793305585
reduction [npop] 0.00117725734917
practice [menp] 0.00117525387708
cardiovascular events [fndg] 0.00117490761194
Children [aggp] 0.00117129178637
Evaluated [ftcn] 0.00116737050378
intervention [hlca] 0.00116498018836
Purpose [ftcn] 0.0011531287397
Therapeutic [topp] 0.00114950679637
Following [tmco] 0.00113716979987
Long [qlco] 0.00113482568308
Information [idcn] 0.00112194809344
C-reactive protein [aapp, imft] 0.00111927817414
Published [ocac] 0.00111163088384
Score [qnco] 0.00110527540434
Irradiation [npop] 0.00110202659522
Limited [ftcn] 0.00109182554489
Improved [qlco] 0.00108268594951
Current [tmco] 0.00108194623123
Often [tmco] 0.00107360248404
Assessed [acty] 0.00107105911881
coronary artery disease [dsyn] 0.00106918767381
Atherosclerosis [dsyn] 0.00106394626907
postmenopausal [tmco] 0.00106362781161
Metabolic syndrome [dsyn] 0.00105530441102
Increasing [ftcn] 0.00105248515456
Benefit [qnco] 0.00104765368648
findings [ftcn] 0.00103738074437
objectives [inpr] 0.00103667619525
national [inpr] 0.00102215123456
search [inpr] 0.0010217738657
Mechanisms [ftcn] 0.00102102321196
People [popg] 0.00101879562689
Independent [idcn] 0.00101339126231
Target [ftcn] 0.00100066231803
days [tmco] 0.000998245918358
Medication [phsu] 0.000995271286407
Aspirin [orch, phsu] 0.000992998119585
Recommended [idcn] 0.000988694831334
Future [tmco] 0.00098541102889
function [phsf] 0.000975315866733
PREVENT [phsu] 0.000973848922089
Hormone replacement therapy [topp] 0.000973478975757
placebo [topp] 0.000970245459308
considered [idcn] 0.000967675264214
Support [medd] 0.000958586410484
Range [qnco] 0.000955474440203
randomized [resa] 0.000954893516661
setting [ftcn] 0.000950961137668
System [ftcn] 0.000948369225809
Knowledge [inpr] 0.000946878148822
Large [qnco] 0.000946146142859
Safety [hcpp] 0.000931213867719
Adjusted [ftcn] 0.000930155481163
Single [popg] 0.000928376378258
interventions [hlca] 0.000924161650059
Aged [orga] 0.000913425256375
Chronic kidney disease [dsyn] 0.000912738147098
symptoms [ftcn] 0.000911313362491
Main [qlco] 0.00090909948497
Make [ftcn] 0.000907180719056
Design [acty] 0.000903564736964
Induced [ftcn] 0.000901847235281
mmHg [qnco] 0.000891916998087
Heart disease [dsyn] 0.000891632475724
Select [acty] 0.000891087967289
Authors [prog] 0.000891073158219
Confidence Intervals [qnco] 0.000890559788122
Adult [aggp] 0.000879855141018
chronic [tmco] 0.000879381656634
Relationship [qlco] 0.000877216749583
Cardiology [bmod] 0.000876323966319
Obesity [dsyn] 0.000875387514568
Medications [phsu] 0.000870940551356
Five [qnco] 0.000869661453334
Elderly [popg] 0.000868047730629
Drug [phsu] 0.000863846098205
History [ocdi] 0.000859357069414
Appropriate [qlco] 0.000856480692541
Update [tmco] 0.000853182577096
lesions [fndg] 0.000846510438752
Severe [qlco] 0.000840481847329
ischaemic heart disease [dsyn] 0.000840121722692
Defined [cnce] 0.000839245484439
Benefits [qnco] 0.000839031282767
Inspiration [orgf] 0.000829845106411
Evaluation [ftcn] 0.00082917864219
Comorbidities [idcn] 0.000827251794395
patient care [hlca] 0.000827103559715
Exercise [dora] 0.000823217080395
experience [menp] 0.000819382619018
Hospital [hcro, mnob] 0.00081795375944
Regression [patf] 0.000816770235804
Breast [bpoc] 0.000816329009002
Conduct [inbe] 0.000813209649905
Decrease [qlco] 0.000809470775913
Marker [clna] 0.00080636749128
Drug Therapy [topp] 0.000797785347637
Lipid [lipd] 0.000794241009818
Medical [ftcn] 0.000793681231921
Effectiveness [qlco] 0.000793297675545
Improvement [cnce] 0.000793067240386
Various [irda] 0.000788506335207
acute [tmco] 0.000786997699236
Risks [qlco] 0.000785961688705
Menopause [phsf] 0.000781983314297
Chemotherapy [topp] 0.000780446687181
Atrial Fibrillation [patf] 0.000773624883166
free [ftcn] 0.000770357180271
Novel [tmco] 0.000767752725215
Cardiovascular Diseases [dsyn] 0.000767504301745
Center [spco] 0.000766644970326
paediatric [bmod] 0.000765764726572
Morbidity [qnco] 0.00076451358878
Parameters [fndg] 0.00076062957984
Diseases [dsyn] 0.000757056219112
Meta-Analysis [inpr] 0.000756742179619
Take [hlca] 0.000754584989782
Addition [ftcn] 0.000753094378502
Several [qnco] 0.000749846581403
Measured [qlco] 0.000747219388608
Female [fndg] 0.000743683129491
Young [tmco] 0.000742811273582
Sex [orgf] 0.000742106334468
Average [qnco] 0.00073841665982
Combined [qlco] 0.000730897020559
Available [ftcn] 0.000726460865649
Drugs [phsu] 0.000725253316171
International [idcn] 0.000722383448365
Burden [idcn] 0.000722026468666
Reducing [qlco] 0.000716994735058
Discharge [bdsu] 0.000715162874595
heart rate [clna] 0.000715117299719
Characteristics [qlco] 0.00071220192509
Article [inpr] 0.000709896110491
Decreased [qnco] 0.000707285458176
vascular [bpoc] 0.000702572747436
Diagnosed [fndg] 0.000699738083186
Examined [fndg] 0.000699475272383
Diet [food] 0.000698709720394
Vascular Malformations [anab] 0.000696928531402
Body Mass Index [diap] 0.000693930537858
Index [inpr] 0.000691759771974
Bleeding [patf] 0.000690101736138
Issue [fndg] 0.000687936607319
investigated [ftcn] 0.00068715465906
Combination [qlco] 0.000686700319787
Dyslipidaemia [dsyn] 0.00068339628517
Sample [sbst] 0.000683224215931
Known [qlco] 0.00068194432033
Literature [inpr] 0.000679347295573
Imaging [diap] 0.000678770562373
Understanding [menp] 0.000678592608435
reviewed [inpr] 0.000678355554413
Assessment [hlca] 0.000676670754787
prescribed [hlca] 0.000675752764075
Represent [acty] 0.000674725389777
Last [qlco] 0.000674505673359
Small [qnco] 0.000673445593374
Needed [qlco] 0.000672846800089
Flow [npop] 0.000671281270874
Models [inpr] 0.000669917924701
criteria [inpr] 0.000669476917156
Prostate Cancer [neop] 0.000669065122817
prospective [resa] 0.000667218024705
LTD [ortf] 0.000664686545333
investigate [ftcn] 0.000660869964347
Profile [lbpr] 0.000657840289379
Well [qlco] 0.000657760456449
Help [socb] 0.00065760118952
Cost Effectiveness [qnco] 0.000657468598106
Review, Systematic [inpr] 0.000657393088875
Relevant [qlco] 0.000657007715099
Play [dora] 0.000655055655133
Standard [qlco] 0.000651941302583
Late [tmco] 0.000651827981526
Cost [qnco] 0.000651146013138
Additional [ftcn] 0.000648556857971
Lung [bpoc] 0.000646502988499
Part [spco] 0.000642071214336
Decade [qnco] 0.000641979164442
coronary [bpoc] 0.000641908070189
Complex [qlco] 0.000641828838484
Required [ftcn] 0.000641022648283
Plasma [bdsu] 0.000640872029244
recommendations [idcn] 0.000638270484663
Post [tmco] 0.000638241924297
Program [cnce] 0.000637464321115
Improving [qlco] 0.000636914276504
Ischaemic [ftcn] 0.000636480965386
APPEAR [qlco] 0.000631394761005
Androgen Deprivation Therapy [topp] 0.000627753799941
Surgical [hlca] 0.000627160280941
Adherence [ftcn] 0.000626743450671
Moderate [qlco] 0.000626536094944
prognostic [inpr] 0.000626332329149
Guide [prog] 0.000623705904603
activity [dora] 0.000622927879616
Screening [hlca] 0.000620795370783
Ratio [qnco] 0.000620109870508
Diagnostic [fndg] 0.000618700263015
Strong [qlco] 0.000617672487281
Tool [mnob] 0.000614829826055
Biomarkers [clna] 0.000610793507112
In [qnco] 0.000610597672129
Multiple [qnco] 0.000608975297066
Normal [qlco] 0.000607592722083
adverse events [fndg] 0.000605152265438
radiation therapy [inpr] 0.000604394658639
Primary Care [hlca] 0.000603389623802
Adults [aggp] 0.000601854174902
Congenital heart disease [cgab, dsyn] 0.00060160602958
Comparison [acty] 0.000600623231916
Revealed [qlco] 0.000600501934424
Ischaemic stroke [dsyn] 0.000600286345922
Risk Ratio [qnco] 0.000598817254361
Six [qnco] 0.0005981178192
Acute Coronary Syndrome [dsyn] 0.000597029131006
randomized controlled trials [inpr, resa] 0.000594917088523
GIVEN [cnce] 0.000593786601575
Stage [tmco] 0.000593072875495
Process [bpoc] 0.000592467781535
deep breath [sosy] 0.000592147211662
Diabetes Mellitus [dsyn] 0.00059050253596
Advance [medd] 0.00058623642436
Secondary Prevention [topp] 0.000585811439129
Few [qnco] 0.000581644113205
Died [orgf] 0.000581598057401
Lupus Erythematosus, Systemic [dsyn] 0.000580552290504
Hospitalization [hlca] 0.0005799423042
Survivors [podg] 0.000579577219371
Occurred [acty] 0.000576515384331
Alone [qnco] 0.000574615505174
Established [qlco] 0.000571833452605
Address [inpr] 0.000570110649246
Smoking [inbe] 0.000569106595659
Measure [qnco] 0.000568687022878
Physical activity [dora] 0.000568225559917
Leading [tmco] 0.000560891620304
Life Style [socb] 0.000559265251271
Focus [spco] 0.000557374007306
society [orgt] 0.000556763312163
lowering [spco] 0.000556447291398
Cholesterol [bacs, strd] 0.000554762108888
Database [inpr] 0.000554583553021
Doses [qnco] 0.000553756287954
Work [ocac] 0.000553435672971
Physicians [prog] 0.00055138542612
Area [geoa] 0.00055024937641
Agent [chvf] 0.000548743418019
Treatments [topp] 0.00054727789633
Likely [qlco] 0.000547045097397
Value [qnco] 0.000546916296408
Affect [menp] 0.000546913034643
Report [inpr] 0.000546338947336
Challenge [clna] 0.000545885720412
Previous [tmco] 0.000545220473464
Inflammatory [ftcn] 0.000542366461669
Multi [qnco] 0.000542142869967
Proportion [qnco] 0.000541024979699
Interaction [ftcn] 0.000538021938778
atorvastatin [orch, phsu] 0.000535215648181
Local [spco] 0.000534196487628
Functional [ftcn] 0.000533323472556
Derived [qlco] 0.000533170293537
Relative [famg] 0.000532762459541
Prescription [hlca] 0.000531919506399
Hold [idcn] 0.000531841267874
Myocardial [spco] 0.000531380047699
Best [qlco] 0.000525601983088
Procedure [diap, topp] 0.000525251716174
Ageing [orgf] 0.000521900914704
Out [spco] 0.000517126936027
Currently [tmco] 0.000516362569721
Predicted [idcn] 0.000516050923677
Obtained [ftcn] 0.000513897291196
Stable [qlco] 0.000512923756781
Pulmonary arterial hypertension [dsyn] 0.000511066195301
strategy [menp] 0.000508174689863
Point [qnco] 0.000506474720217
Postoperative [tmco] 0.000505596225345
lack [qlco] 0.00050495078146
PLAN [dsyn] 0.0005045746863
Education [edac] 0.000503449203249
mice [mamm] 0.000502646696615
weeks [tmco] 0.000500888879334
Region [geoa] 0.000500670419897
Link [inpr] 0.000499811827878
Non-alcoholic Fatty Liver Disease [dsyn] 0.000499389407964
High sensitivity [lbpr] 0.000498909990173
Provided [acty] 0.000497873310599
Damage [inpo] 0.000496604034767
Depression [mobd] 0.000494405196721
Pulmonary Hypertension [dsyn] 0.000493711947992
Calculated [ftcn] 0.000493423573158
Glomerular Filtration Rate [diap] 0.000493103863626
Clinical Trials [resa] 0.000492207108511
Searched [acty] 0.00049214949261
variables [qlco] 0.000490942721066
Magnetic Resonance Imaging [diap] 0.000488764970663
Pre-operative [tmco] 0.00048724935804
Gender [orga] 0.000484886663523
Structural [spco] 0.00048366733826
Ethanol [orch] 0.00048059116206
Presented [idcn] 0.000480136629177
Age-Years [tmco] 0.000479966964916
left sided [spco] 0.00047973725301
Affected [ftcn] 0.000478269141026
Percutaneous [spco] 0.000478217140594
Therapies [topp] 0.000477827718494
Pain [sosy] 0.000476411224266
techniques [inpr] 0.000476148021923
Observational Study [resa] 0.000475235705512
topic4
P NOS [aapp, imft] 0.010245714636
treatment [ftcn] 0.00773143919856
Study [mnob] 0.00659197661898
Cardiovascular disease [dsyn] 0.00623951566869
CARDIOVASCULAR [bdsy] 0.00600781777476
Women [popg] 0.0057360232975
Methods [inpr] 0.00449992581249
Group [idcn] 0.00434469812582
Compared [acty] 0.00402861802447
Mortality [qnco] 0.00395583036374
Increased [qnco] 0.00389557015401
Hypertension [dsyn] 0.0035598340011
Based [ftcn] 0.003484935399
treated [topp] 0.00312587965632
Age [orga] 0.00307957377545
Conclusions [idcn] 0.00303939820653
therapy [ftcn] 0.00302736516112
included [ftcn] 0.00276296561959
Trial [resa] 0.00276081239694
Survival [acty] 0.00275234146161
radiotherapy [inpr] 0.00265122567282
risk factors [qnco] 0.00253097800035
Dose [qnco] 0.00235687018448
Health [idcn] 0.0023329274651
Association [menp] 0.00232986152219
Heart [bpoc] 0.00230495474827
N NOS [aapp, imft] 0.00226986751234
Cardiac [bpoc] 0.00223102210951
Efficacy [qlco] 0.00221834755734
Hazard Ratio [qnco] 0.00216424513688
participants [popg] 0.00215533573089
Suggest [idcn] 0.00210735876449
Evaluate [ftcn] 0.00205685410436
effects [qlco] 0.00203514062768
High Risk [qlco] 0.0020106256841
Reserve [acty] 0.00196550777301
Quality [qlco] 0.00189582606526
Odds Ratio [qnco] 0.00181123983096
Complications [patf] 0.00180280009418
Old [tmco] 0.00179173807677
Cases [ftcn] 0.00179137750266
Including [ftcn] 0.00175672981633
coronary heart disease [dsyn] 0.00174578561035
Men [popg] 0.00173312758369
Reported [inpr] 0.00172170426336
Stroke [dsyn] 0.00171555839888
months [tmco] 0.00171185745272
Heart failure [dsyn] 0.00169794188023
Breast Cancer [neop] 0.00164955691547
intervention [hlca] 0.00160026784904
baseline [bodm] 0.00159546340086
Care [acty] 0.00158501709782
Specific [qlco] 0.00156576150186
Blood Pressure [orgf] 0.00155410283274
Performed [ftcn] 0.00155155081694
Surgery [bmod] 0.00154304564752
Reduced [qlco] 0.00154141059286
Management [ocac] 0.00152563095623
effective [qlco] 0.00152222151073
Observed [ftcn] 0.00150915913594
Target [ftcn] 0.0014881392104
Subject [grup] 0.00147776752209
Diabetes [dsyn] 0.00147262655945
Present [qnco] 0.00146805888635
Statin [orch, phsu] 0.00146219975552
Primary [qlco] 0.00145889795647
Metabolic syndrome [dsyn] 0.00145623258795
GY [geoa] 0.00144351601943
Purpose [ftcn] 0.00143054207342
Levels [qlco] 0.0014288231051
reduction [npop] 0.00141999278158
cardiovascular events [fndg] 0.0014083371662
IMPACT [gngm] 0.00138976048604
Assessed [acty] 0.00138531157332
Young [tmco] 0.00135422727048
Measured [qlco] 0.00134784509194
Guidelines [inpr] 0.00134616221925
strategies [menp] 0.0013019547023
Identified [qlco] 0.00129062885587
Life [idcn] 0.00128014368652
Objective [inpr] 0.00127486797755
Venous malformation [anab] 0.00126368328998
Information [idcn] 0.00125673643479
Radiation [npop] 0.00125665181699
Irradiation [npop] 0.0012540258945
Need [qlco] 0.00125016899237
Drug [phsu] 0.00124874220609
Parameters [fndg] 0.00124331216393
Events [evnt] 0.0012212820206
Received [qlco] 0.00121305136821
Current [tmco] 0.00120122488825
Improvement [cnce] 0.00119376529336
Induced [ftcn] 0.00117891477404
PREVENT [phsu] 0.00117445065259
Prevention [topp] 0.00117278338986
Sclerotherapy [topp] 0.00116795786567
Decreased [qnco] 0.00116669766017
Evaluated [ftcn] 0.00116477251519
Controlled [ftcn] 0.00115847541429
condition [dsyn] 0.00114423612921
Update [tmco] 0.00114211741334
Available [ftcn] 0.00113521786199
Range [qnco] 0.00113325668025
Score [qnco] 0.00112175599679
practice [menp] 0.00110366858536
interventions [hlca] 0.00110334824494
radiation therapy [inpr] 0.00109765147167
Approach [spco] 0.00109610221648
symptoms [ftcn] 0.00109062103996
Single [popg] 0.0010752881226
Needed [qlco] 0.00107423898184
Benefit [qnco] 0.00105685747423
Myocardial Infarction [dsyn] 0.0010521421967
Known [qlco] 0.00105126467478
Long [qlco] 0.00103886386615
experience [menp] 0.00103573492052
Support [medd] 0.00102618410335
postmenopausal [tmco] 0.00101948219073
Large [qnco] 0.00101914972695
considered [idcn] 0.00101556162807
findings [ftcn] 0.00100309749293
People [popg] 0.00100281926938
Safety [hcpp] 0.00100244337917
Drugs [phsu] 0.00100040552831
Address [inpr] 0.000999603484649
Aspirin [orch, phsu] 0.000998541728544
Therapeutic [topp] 0.000996744340136
Statins [orch, phsu] 0.00099129798114
Estimated [qnco] 0.000981569808297
Survivors [podg] 0.000979832272947
Published [ocac] 0.00097884868038
ischaemic heart disease [dsyn] 0.000977555487011
Main [qlco] 0.000976972534505
Assessment [hlca] 0.00097238056465
Children [aggp] 0.000971499194704
Diagnosed [fndg] 0.000967619585272
placebo [topp] 0.000956864378829
Drug Therapy [topp] 0.000954002251302
Design [acty] 0.000953969961935
Following [tmco] 0.000946424769826
Improved [qlco] 0.000944302586242
Conduct [inbe] 0.000935425430289
Elderly [popg] 0.000932917438262
Combination [qlco] 0.000932630033213
Appropriate [qlco] 0.000925538450196
Authors [prog] 0.000923523866802
vascular [bpoc] 0.000921370934996
Effectiveness [qlco] 0.000917714660307
Examined [fndg] 0.000916843982131
Menopause [phsf] 0.000915800734252
Diseases [dsyn] 0.000905255182073
Increasing [ftcn] 0.000902546584901
Relationship [qlco] 0.000896077945809
Atherosclerosis [dsyn] 0.000891680423651
Defined [cnce] 0.000891054682266
Hormone replacement therapy [topp] 0.000888180316388
Sex [orgf] 0.000886808214798
days [tmco] 0.000885567885001
Decrease [qlco] 0.000884217424655
Medications [phsu] 0.000883469380244
Limited [ftcn] 0.000880944128303
Make [ftcn] 0.00088005311345
Future [tmco] 0.000878856978466
function [phsf] 0.000877101553282
Atrial Fibrillation [patf] 0.000873687893119
Heart disease [dsyn] 0.000862964834949
randomized [resa] 0.000862020036255
Combined [qlco] 0.000859321509757
Hospital [hcro, mnob] 0.000859032867068
Often [tmco] 0.000854911065949
Receive [qlco] 0.000854454116411
System [ftcn] 0.000851257028662
Pulmonary Hypertension [dsyn] 0.000848256691864
search [inpr] 0.00084406444115
Addition [ftcn] 0.000843461502864
History [ocdi] 0.000843405849874
Prognostic Factor [clna] 0.000840505803362
Index [inpr] 0.000839741572537
Chemotherapy [topp] 0.000838788230421
Obesity [dsyn] 0.000838255627115
Meta-Analysis [inpr] 0.000835452051565
Article [inpr] 0.000835439625911
acute [tmco] 0.000834969500047
Ratio [qnco] 0.000827344689744
Review, Systematic [inpr] 0.000825075292703
Aged [orga] 0.000824957818479
Help [socb] 0.000824580278401
Comorbidities [idcn] 0.000823949933213
coronary artery disease [dsyn] 0.000822049915133
Independent [idcn] 0.00081622574248
Evaluation [ftcn] 0.000806714385293
Severe [qlco] 0.000804327531926
investigated [ftcn] 0.000803904934491
Complex [qlco] 0.000796737744047
setting [ftcn] 0.00079636897046
Alone [qnco] 0.000795240975106
Select [acty] 0.000790734695785
Breast [bpoc] 0.000788074134101
Revealed [qlco] 0.000783905776621
Androgen Deprivation Therapy [topp] 0.000782314211753
free [ftcn] 0.000772412564817
Adults [aggp] 0.000771695945863
objectives [inpr] 0.000770026285417
Represent [acty] 0.000768932040489
Five [qnco] 0.00076681490957
Exercise [dora] 0.000763280408602
Medication [phsu] 0.000760045859729
Various [irda] 0.000757462966738
Adjusted [ftcn] 0.000755353376714
society [orgt] 0.000749996549481
Morbidity [qnco] 0.000749920046202
Acute Coronary Syndrome [dsyn] 0.000749846239831
Prostate Cancer [neop] 0.000745593451717
Obtained [ftcn] 0.00074183065333
Multiple [qnco] 0.000741590305764
Recommended [idcn] 0.000741478014722
Well [qlco] 0.000736884277641
Primary Care [hlca] 0.000735270717027
Relevant [qlco] 0.000735242212038
Oral [spco] 0.000734350228604
Optimal [qlco] 0.000734146694494
Additional [ftcn] 0.000733576455744
patient care [hlca] 0.00073262064934
Consecutive [qlco] 0.000732274050582
Body Mass Index [diap] 0.00072751495645
Concern [idcn] 0.000724419848459
Functional [ftcn] 0.000723965557324
mmHg [qnco] 0.000718982785183
Previous [tmco] 0.000718515007706
Database [inpr] 0.00071413099267
Searched [acty] 0.000712370347213
Lipid [lipd] 0.000710470355618
Life Style [socb] 0.000706378606477
Proportion [qnco] 0.000705999851811
Cost Effectiveness [qnco] 0.000705461042712
Characteristics [qlco] 0.000703820964165
coronary [bpoc] 0.000703763665462
Imaging [diap] 0.000703380842601
Profile [lbpr] 0.000702638911746
Collected [idcn] 0.000701877274276
Knowledge [inpr] 0.000699776308722
Tool [mnob] 0.000697872378236
Issue [fndg] 0.000696417712047
Literature [inpr] 0.00069630359831
Adherence [ftcn] 0.000692664402783
Mechanisms [ftcn] 0.000691820220695
variables [qlco] 0.000691490515173
Medical [ftcn] 0.000690000694617
Last [qlco] 0.000689828595694
cardiovascular risk factor [dsyn] 0.000685125665627
Benefits [qnco] 0.000684353351861
investigate [ftcn] 0.000679332052114
heart rate [clna] 0.000676947791485
Response [orga] 0.000674560959712
Several [qnco] 0.000673346917822
Treatments [topp] 0.000672285533043
Comparison [acty] 0.000671652426089
Adult [aggp] 0.00066780520001
Focus [spco] 0.000666063250097
LTD [ortf] 0.000663859046408
C-reactive protein [aapp, imft] 0.000662629246562
Discharge [bdsu] 0.00066208483936
GIVEN [cnce] 0.000661042810264
recommendations [idcn] 0.000657717799668
Regression [patf] 0.000657050114939
Dyslipidaemia [dsyn] 0.000656956421216
strategy [menp] 0.000655845323231
Cardiovascular Diseases [dsyn] 0.000654446729451
Small [qnco] 0.000653790849575
Models [inpr] 0.000649553570171
Affect [menp] 0.000648467353217
Daily [tmco] 0.000647288271512
Screening [hlca] 0.000647064187616
chronic [tmco] 0.000645790959726
Bleeding [patf] 0.000642633858297
Biomarkers [clna] 0.00063752104388
criteria [inpr] 0.000636870945198
Established [qlco] 0.000631980952868
prognostic [inpr] 0.000631634799576
Burden [idcn] 0.000622959260596
Polypharmacy [fndg] 0.000622082386897
Damage [inpo] 0.00062103784014
Ischaemic [ftcn] 0.000620947575276
procedures [inpr] 0.000619883672245
Diet [food] 0.000619728383794
Cardiology [bmod] 0.000619634471913
Comprehensive [qlco] 0.000618559394671
Guide [prog] 0.000616997106888
Standard [qlco] 0.000613724048194
APPEAR [qlco] 0.000613703567905
Hold [idcn] 0.000612405491365
Congenital heart disease [cgab, dsyn] 0.000611806483481
Non-alcoholic Fatty Liver Disease [dsyn] 0.000610144926363
adverse events [fndg] 0.000607027912542
Strong [qlco] 0.00060444248361
side effects [ftcn] 0.000602246408491
Novel [tmco] 0.000600226054895
Smoking [inbe] 0.000599842677137
Value [qnco] 0.000597821351455
Depression [mobd] 0.000597660856367
Doses [qnco] 0.000595934002326
national [inpr] 0.000590740118123
Interaction [ftcn] 0.000590364797252
Marker [clna] 0.000587785645602
Area [geoa] 0.0005873848296
Confidence Intervals [qnco] 0.000586642037897
Six [qnco] 0.000579216773759
In [qnco] 0.000578698280213
prescribed [hlca] 0.000574745967561
Surgical [hlca] 0.000573837136112
Play [dora] 0.000572814260841
retrospective [resa] 0.000571082524116
Associations [menp] 0.000570807312451
secondary [neop] 0.000570309125687
Exposure NOS [inpo] 0.000568891246808
Center [spco] 0.000564954430641
Understanding [menp] 0.000564804836835
Ischaemic stroke [dsyn] 0.000562462717069
Female [fndg] 0.000561622574142
Occurred [acty] 0.000559828971455
Likely [qlco] 0.000557429486299
mice [mamm] 0.000556627780421
Currently [tmco] 0.000555444921647
Work [ocac] 0.00055538064917
Procedure [diap, topp] 0.00055529676854
High dose [qnco] 0.000554958549567
Record [inpr] 0.000554521861941
Late [tmco] 0.000554441650853
Clinical Trials [resa] 0.00055191151836
Therapies [topp] 0.000551409124371
Central [spco] 0.000550805393316
Lung [bpoc] 0.000548899906305
methodology [inpr] 0.000548755291113
Leading [tmco] 0.000548351996998
Chronic kidney disease [dsyn] 0.000546380590721
Percutaneous Coronary Intervention [topp] 0.000540171998828
weeks [tmco] 0.0005377248095
If [qlco] 0.000536639611637
Elevated [qlco] 0.000535628520146
Improving [qlco] 0.000533124890563
Physical activity [dora] 0.000532597404304
Venous Thromboembolism [patf] 0.000531972569804
Guideline [inpr] 0.000531235657721
Bias [idcn] 0.000528323453649
lowering [spco] 0.000528052302816
Global [spco] 0.000528038427386
lesions [fndg] 0.000527484462403
Multi [qnco] 0.000526112087515
Relative Risk [qnco] 0.000524798796449
End [spco] 0.000524707708666
Systemic [ftcn] 0.000524359700861
Contribute [acty] 0.000520617377065
hypertensive [fndg] 0.000520544603888
randomized controlled trials [inpr, resa] 0.00052022305587
Prescription [hlca] 0.000518079394434
deaths [orgf] 0.00051781167905
Acute myocardial infarction [dsyn] 0.000516264645746
Stage [tmco] 0.000515976630082
Moderate [qlco] 0.000515004573731
Risk Ratio [qnco] 0.000513506681621
Age-Years [tmco] 0.00051274627467
activity [dora] 0.000512448186358
Risks [qlco] 0.000510951592672
Questionnaire [inpr] 0.000509762047239
Normal [qlco] 0.000507892080738
Average [qnco] 0.000506904736355
Advance [medd] 0.000506426405438
Diagnostic [fndg] 0.000505048454169
Pulmonary arterial hypertension [dsyn] 0.000504548835746
Duration [tmco] 0.000503822029757
Education [edac] 0.000502957800568
Take [hlca] 0.000502817393124
paediatric [bmod] 0.000502305820968
Technique [ftcn] 0.000499877611965
Hospitalization [hlca] 0.000499785060123
Inspiration [orgf] 0.000499466576954
Test [lbpr] 0.000497915708596
Program [cnce] 0.0004978733681
Diabetes Mellitus [dsyn] 0.000497719275322
Hodgkin Lymphoma [neop] 0.000497546565167
Applied [hlca] 0.000496564024451
techniques [inpr] 0.000496289290808
Physicians [prog] 0.00049627037737
Calculated [ftcn] 0.000495104205528
lack [qlco] 0.000494639570205
randomized controlled trial [inpr, resa] 0.000494208860071
progression [patf] 0.000494101413743
International [idcn] 0.000493613342419
Approaches [spco] 0.000492437709519
Of [spco] 0.000491264654364
Few [qnco] 0.00049067280902
Decade [qnco] 0.000484626871532
left sided [spco] 0.000483307106567
Recently [tmco] 0.000481512058712
Died [orgf] 0.00047969752964
reviewed [inpr] 0.000479423088863
Agent [chvf] 0.000478483130822
Neck [blor] 0.000477196019685
Head [blor] 0.00047686050655
Part [spco] 0.000476464539431
topic5
P NOS [aapp, imft] 0.0113168282534
treatment [ftcn] 0.0100043255971
Study [mnob] 0.00680782942818
Group [idcn] 0.00650522611436
Cardiovascular disease [dsyn] 0.00559766331359
Women [popg] 0.00549533881627
Increased [qnco] 0.00493828515289
Based [ftcn] 0.00474728068849
Compared [acty] 0.00395262628756
Methods [inpr] 0.00388789315484
Age [orga] 0.00383905267807
CARDIOVASCULAR [bdsy] 0.00365400823749
Mortality [qnco] 0.00357689534985
Trial [resa] 0.00338590361614
Hypertension [dsyn] 0.00335877177055
therapy [ftcn] 0.00313724457093
Conclusions [idcn] 0.00306029574771
included [ftcn] 0.00283384934435
radiotherapy [inpr] 0.0026819118739
participants [popg] 0.00264856534867
Including [ftcn] 0.00254114187868
Health [idcn] 0.00244578849885
Dose [qnco] 0.00241712272381
Hazard Ratio [qnco] 0.0023998339899
Cardiac [bpoc] 0.00237278352701
treated [topp] 0.00231510603876
Diabetes [dsyn] 0.0022922372901
risk factors [qnco] 0.00222400209528
Management [ocac] 0.00217532525174
Men [popg] 0.0021700056154
Old [tmco] 0.00213003024742
N NOS [aapp, imft] 0.00212069432816
Breast Cancer [neop] 0.0020971687933
months [tmco] 0.00200552534874
Association [menp] 0.00189798540933
Survival [acty] 0.00184700337924
Heart [bpoc] 0.00183795622884
Heart failure [dsyn] 0.0017815784341
Specific [qlco] 0.00177783502489
effects [qlco] 0.00176094961834
Stroke [dsyn] 0.00173439764902
Range [qnco] 0.00169755651872
Identified [qlco] 0.00168529153169
reduction [npop] 0.00167024047479
baseline [bodm] 0.0016485763005
Reported [inpr] 0.00164719670667
Primary [qlco] 0.0016402621802
Assessed [acty] 0.00162977521697
Observed [ftcn] 0.00160675820535
Care [acty] 0.00160280048548
Quality [qlco] 0.00159913068171
Conduct [inbe] 0.00155597672843
Subject [grup] 0.00154899446557
Blood Pressure [orgf] 0.00154484299875
Performed [ftcn] 0.0015382648254
Myocardial Infarction [dsyn] 0.00153766083348
IMPACT [gngm] 0.00151263414362
Present [qnco] 0.00148715484026
Prevention [topp] 0.00148113607324
Received [qlco] 0.00148040903969
Reduced [qlco] 0.00147461544582
Current [tmco] 0.00145220141329
Statins [orch, phsu] 0.00143763241798
condition [dsyn] 0.00143116929043
Estimated [qnco] 0.001426377009
Evaluate [ftcn] 0.00142308050618
Objective [inpr] 0.0013985325838
search [inpr] 0.00139209097965
coronary heart disease [dsyn] 0.00139163418577
Purpose [ftcn] 0.00136694038627
cardiovascular events [fndg] 0.00135857996967
Drug [phsu] 0.0013556478451
GY [geoa] 0.00135400696031
effective [qlco] 0.00134757991491
Surgery [bmod] 0.00133746226959
Suggest [idcn] 0.00131232353988
Need [qlco] 0.00130088025512
Levels [qlco] 0.00128290911694
Support [medd] 0.00126965098558
Statin [orch, phsu] 0.00126858015422
High Risk [qlco] 0.0012550098975
Complications [patf] 0.00125140783797
Safety [hcpp] 0.00123561706103
Reserve [acty] 0.00122954074504
postmenopausal [tmco] 0.00121682756937
Approach [spco] 0.00120613472835
Children [aggp] 0.00119353490868
Single [popg] 0.00117820218305
Controlled [ftcn] 0.0011705229944
Benefit [qnco] 0.00116832902471
Metabolic syndrome [dsyn] 0.00116291232928
Receive [qlco] 0.00114484186392
practice [menp] 0.00114421249865
Improvement [cnce] 0.0011399030316
Published [ocac] 0.00112714384803
Odds Ratio [qnco] 0.00112650334759
Induced [ftcn] 0.00112550033566
Evaluated [ftcn] 0.00112517830728
Target [ftcn] 0.00110698673501
Radiation [npop] 0.00110237835424
Aged [orga] 0.00109630678505
Make [ftcn] 0.00108108102271
Chemotherapy [topp] 0.00107597454057
Drugs [phsu] 0.00107548384744
Evaluation [ftcn] 0.00106158800347
Several [qnco] 0.0010611866673
Authors [prog] 0.00106047265274
intervention [hlca] 0.0010569525902
Venous malformation [anab] 0.00105380294499
Independent [idcn] 0.00104881102747
Following [tmco] 0.00101931404706
Adjusted [ftcn] 0.00101693481219
Irradiation [npop] 0.00101655136856
Design [acty] 0.00101377750936
System [ftcn] 0.0010073287869
Prognostic Factor [clna] 0.000995528990484
Sclerotherapy [topp] 0.000994661127618
ischaemic heart disease [dsyn] 0.000989893966362
vascular [bpoc] 0.000988148692451
Multiple [qnco] 0.000987266163628
Efficacy [qlco] 0.000984452122249
Available [ftcn] 0.000981773852209
Article [inpr] 0.000981679813425
Effectiveness [qlco] 0.000979486481374
Index [inpr] 0.000974730920027
Information [idcn] 0.000969544549102
Heart disease [dsyn] 0.000963642818704
Limited [ftcn] 0.000963320211516
Main [qlco] 0.000962920578533
Events [evnt] 0.000958231420414
Hormone replacement therapy [topp] 0.000957796771807
Pulmonary Hypertension [dsyn] 0.000955066980327
Well [qlco] 0.00095472499466
Stage [tmco] 0.000954279434942
Guidelines [inpr] 0.000945901795081
Young [tmco] 0.000942038444998
Drug Therapy [topp] 0.000939452695975
Smoking [inbe] 0.000937754068483
Cases [ftcn] 0.000931754795303
Increasing [ftcn] 0.000929236593271
Burden [idcn] 0.000928937415139
Diagnosed [fndg] 0.000928446325914
objectives [inpr] 0.00092802032212
Life [idcn] 0.00092690683472
Survivors [podg] 0.000924954395024
Measured [qlco] 0.000921054893287
PREVENT [phsu] 0.000921015503981
coronary artery disease [dsyn] 0.000917428666563
Six [qnco] 0.000915734497561
Breast [bpoc] 0.000910441512631
Decreased [qnco] 0.000908393021662
Aspirin [orch, phsu] 0.000907139495147
Recommended [idcn] 0.000905416494696
Menopause [phsf] 0.000898585850513
Ratio [qnco] 0.00089549135934
Relationship [qlco] 0.000894586261682
Morbidity [qnco] 0.00089397168204
Comorbidities [idcn] 0.000891115101145
Hospital [hcro, mnob] 0.000887658799442
Large [qnco] 0.00087858272447
findings [ftcn] 0.000878326471666
Decrease [qlco] 0.000873456591562
Often [tmco] 0.000870251605978
Long [qlco] 0.000867661745788
Combination [qlco] 0.00086604441189
radiation therapy [inpr] 0.000865603684005
national [inpr] 0.000862561673949
Lipid [lipd] 0.000857359563927
lesions [fndg] 0.000855981906555
Score [qnco] 0.000850209971185
adverse events [fndg] 0.000843018841504
strategies [menp] 0.000840722220582
days [tmco] 0.000838326210521
Response [orga] 0.000835755538075
Update [tmco] 0.000831651445432
considered [idcn] 0.000828956332047
Defined [cnce] 0.000824127616986
Review, Systematic [inpr] 0.000820300215849
Improved [qlco] 0.000820059472563
Surgical [hlca] 0.000818075230275
symptoms [ftcn] 0.000814717653054
investigate [ftcn] 0.000811429484254
Medications [phsu] 0.000805629527581
Atherosclerosis [dsyn] 0.000801327684599
Five [qnco] 0.00079901847098
Needed [qlco] 0.00079834458111
heart rate [clna] 0.000796549948262
Adult [aggp] 0.000796293701363
Functional [ftcn] 0.00079368750184
Discharge [bdsu] 0.000793230017797
Select [acty] 0.000792915861894
Cardiovascular Diseases [dsyn] 0.000785697779526
patient care [hlca] 0.00078471987066
Revealed [qlco] 0.00078340931445
Associations [menp] 0.00078329475304
Profile [lbpr] 0.000782666598776
Diseases [dsyn] 0.000781490687607
Cholesterol [bacs, strd] 0.000777315059367
society [orgt] 0.000773507523453
setting [ftcn] 0.000772586834624
Therapeutic [topp] 0.000772079031582
LTD [ortf] 0.000771248488341
interventions [hlca] 0.000768483946214
Comparison [acty] 0.000767267244108
Androgen Deprivation Therapy [topp] 0.000766653853641
Acute Coronary Syndrome [dsyn] 0.000765333789835
Novel [tmco] 0.000757550123139
Life Style [socb] 0.000753893972635
Improving [qlco] 0.000751934371439
Assessment [hlca] 0.000748811841518
Chronic kidney disease [dsyn] 0.000748043329583
Established [qlco] 0.000744588899134
Atrial Fibrillation [patf] 0.000743510300005
Known [qlco] 0.000741281669558
acute [tmco] 0.000739827860334
Diabetes Mellitus [dsyn] 0.000737190232622
Moderate [qlco] 0.00073491143442
placebo [topp] 0.000734820666706
Medication [phsu] 0.000731951217555
free [ftcn] 0.000726756213534
Small [qnco] 0.000726002758747
Average [qnco] 0.000723308416019
Characteristics [qlco] 0.000721483983415
Occurred [acty] 0.000712831058173
Normal [qlco] 0.000712529998798
Medical [ftcn] 0.000709432964679
Future [tmco] 0.000709139493256
chronic [tmco] 0.000703022626081
Physical activity [dora] 0.000700524333139
mmHg [qnco] 0.000696594720271
Prostate Cancer [neop] 0.000696040424875
Bleeding [patf] 0.000694780760203
Part [spco] 0.000693152520176
History [ocdi] 0.000691890154383
Affect [menp] 0.000690677780639
Cost Effectiveness [qnco] 0.000685805099747
Combined [qlco] 0.00068424519439
Confidence Intervals [qnco] 0.000682927042639
Polypharmacy [fndg] 0.000682839768213
investigated [ftcn] 0.000675188588617
Hold [idcn] 0.000674738319474
Oral [spco] 0.000673887564542
Addition [ftcn] 0.000671132773801
Complex [qlco] 0.000670742387769
Process [bpoc] 0.000667968255974
Diagnostic [fndg] 0.000665346727331
Mechanisms [ftcn] 0.000663666246331
People [popg] 0.000663255034629
Gender [orga] 0.000662752928363
Standard [qlco] 0.000662671254879
Status [qlco] 0.000662112564144
experience [menp] 0.000660685938634
Appropriate [qlco] 0.000660154036807
Screening [hlca] 0.000660023111283
Local [spco] 0.000659211502572
randomized [resa] 0.000658807587076
Reducing [qlco] 0.000658401906676
Previous [tmco] 0.000657541866713
Parameters [fndg] 0.000657299190542
Leading [tmco] 0.000654343849761
Elderly [popg] 0.000653033410444
Various [irda] 0.000652325142605
Optimal [qlco] 0.000651614772989
Address [inpr] 0.000643860638511
Good [qlco] 0.000643754748399
Dyslipidaemia [dsyn] 0.000642882656201
Severe [qlco] 0.000641946822309
C-reactive protein [aapp, imft] 0.000639921435381
Estrogen [horm, phsu, strd] 0.000634764715266
Examined [fndg] 0.000633177551741
atorvastatin [orch, phsu] 0.000631710267626
Vascular Malformations [anab] 0.000631325630615
Models [inpr] 0.000628342308443
Primary Care [hlca] 0.000624319155934
Female [fndg] 0.000623450279522
Late [tmco] 0.000622488668124
Obtained [ftcn] 0.000617092523385
reviewed [inpr] 0.0006162482419
Therapies [topp] 0.000616218452904
Diet [food] 0.000615452456256
Duration [tmco] 0.000614516412454
coronary [bpoc] 0.000611772414064
Exercise [dora] 0.000611676835483
Collected [idcn] 0.000611511580916
Relevant [qlco] 0.000611492849196
Imaging [diap] 0.000610465972963
prognostic [inpr] 0.000607759454093
Literature [inpr] 0.000606625092998
Adherence [ftcn] 0.000606376636637
Adults [aggp] 0.000605795488724
Biomarkers [clna] 0.000605170286962
Knowledge [inpr] 0.000605001345956
recommendations [idcn] 0.000602911171691
Comprehensive [qlco] 0.000602230361533
lowering [spco] 0.000599764390212
function [phsf] 0.0005988797093
Regression [patf] 0.000598585078205
Body Mass Index [diap] 0.000595313881498
Database [inpr] 0.000594927034048
Ischaemic [ftcn] 0.000594162040406
Link [inpr] 0.000593582205321
Risk Ratio [qnco] 0.000590095959335
mice [mamm] 0.000588586300648
Obesity [dsyn] 0.000588086052536
variables [qlco] 0.000586871026105
Congenital heart disease [cgab, dsyn] 0.000586664604384
Help [socb] 0.000586607797501
criteria [inpr] 0.000585387131977
Likely [qlco] 0.000583023613647
weeks [tmco] 0.000581835361345
Fatal [qlco] 0.000581290207424
Take [hlca] 0.00058018622743
Cardiology [bmod] 0.00058008843534
prospective [resa] 0.000577206630498
Represent [acty] 0.000576944117089
randomized controlled trials [inpr, resa] 0.000576750794071
In [qnco] 0.000574131079518
Consecutive [qlco] 0.000571379090621
Complete [qlco] 0.000570461883825
Searched [acty] 0.000568349363631
Additional [ftcn] 0.000565877111632
cardiovascular risk factor [dsyn] 0.000565462587474
Questionnaire [inpr] 0.000565363642758
Agent [chvf] 0.000564576738979
High dose [qnco] 0.000562602843131
Clinical Trials [resa] 0.000561607186209
Currently [tmco] 0.000559608101889
Non-alcoholic Fatty Liver Disease [dsyn] 0.000559089666993
Died [orgf] 0.000558947418103
Play [dora] 0.000557624051591
procedures [inpr] 0.000556001150781
Ageing [orgf] 0.000555993967699
Report [inpr] 0.000553792801323
PLAN [dsyn] 0.000548171859156
Second [qnco] 0.000548155132109
Action [ftcn] 0.000546183378728
Physicians [prog] 0.000543400270236
APPEAR [qlco] 0.00054337484857
Alone [qnco] 0.000541618372306
Test [lbpr] 0.000540425173766
Stable [qlco] 0.000537506872764
Central [spco] 0.000537481557861
Inflammatory [ftcn] 0.000536948633939
secondary [neop] 0.000536011447885
Last [qlco] 0.000535616419161
activity [dora] 0.000533996415594
Focus [spco] 0.000524117369295
Correlation [qlco] 0.00052383907364
VALVE [medd] 0.000516045894072
Doses [qnco] 0.000515935387112
Decade [qnco] 0.000514141777144
Seven [qnco] 0.000513618665251
Guide [prog] 0.00051347147421
Lung [bpoc] 0.000513350929472
???lead [elii, hops] 0.00051065277011
Best [qlco] 0.00051053497053
Flow [npop] 0.000510359726508
Countries [geoa] 0.000508590547611
deep breath [sosy] 0.000506056713236
size [spco] 0.000505811362002
Proportion [qnco] 0.000505484056861
Derived [qlco] 0.000505315672854
Values [qlco] 0.000505176166359
Inspiration [orgf] 0.000504114810407
Challenge [clna] 0.000502598152148
Sex [orgf] 0.000499283003902
Pulse Wave Velocity [phsf, qnco] 0.000499039651013
Metabolic [ftcn] 0.000498981324338
Marker [clna] 0.000495480568702
Hormone Therapy [topp] 0.000494454764633
Understanding [menp] 0.000493069123983
Depression [mobd] 0.000490935850979
Meta-Analysis [inpr] 0.00049069207093
College [mnob] 0.000489755479429
Procedure [diap, topp] 0.000489224669262
left sided [spco] 0.000486937403063
Damage [inpo] 0.000485306356431
Hospitalization [hlca] 0.000485149707284
Prescription [hlca] 0.000485091001964
Bias [idcn] 0.000484616977273
American [popg] 0.000484478820788
treating [topp] 0.000483940324925
atherosclerotic [ftcn] 0.000483473390511
Record [inpr] 0.000483265778664
statistically significant [qnco] 0.000483109591843
Elevated [qlco] 0.00048136003443
Out [spco] 0.000479376937109
Relative [famg] 0.000478713552501
Benefits [qnco] 0.000478576207102
surveillance [ftcn] 0.000477639391565
Low Risk [fndg] 0.000477257625076
Human [humn] 0.000476434628104
Contribute [acty] 0.000476349832457
Plasma [bdsu] 0.00047612255712
Lupus Erythematosus, Systemic [dsyn] 0.000475112684241
paediatric [bmod] 0.000474918337811
Concern [idcn] 0.000473514036201
Cardiac rehabilitation [topp] 0.000473463159785
Inflammation [patf] 0.000469498414215
Treatments [topp] 0.000469330850915
topic6
treatment [ftcn] 0.00936492608418
Study [mnob] 0.00862878718463
P NOS [aapp, imft] 0.00854170114607
Women [popg] 0.00629309313204
Group [idcn] 0.00567471110935
Increased [qnco] 0.00493924538415
Methods [inpr] 0.00435388773886
Age [orga] 0.00420577564464
Mortality [qnco] 0.00416974651783
Cardiovascular disease [dsyn] 0.00394072566754
CARDIOVASCULAR [bdsy] 0.00391862266011
Based [ftcn] 0.00363004015899
Old [tmco] 0.00338864252938
Hypertension [dsyn] 0.00322881596055
Diabetes [dsyn] 0.00304468984555
Compared [acty] 0.00301271434731
Trial [resa] 0.00300137288807
Conclusions [idcn] 0.00286594789868
included [ftcn] 0.00278263652882
N NOS [aapp, imft] 0.00251875088253
Efficacy [qlco] 0.00248888921016
effects [qlco] 0.00247431347406
Management [ocac] 0.00245086672758
treated [topp] 0.00236515069116
Including [ftcn] 0.00235277190516
Cardiac [bpoc] 0.00229158313411
Dose [qnco] 0.00226252476214
radiotherapy [inpr] 0.00225975471593
participants [popg] 0.00201215098362
coronary heart disease [dsyn] 0.00199721861527
Quality [qlco] 0.0018478278373
Present [qnco] 0.00179651443639
therapy [ftcn] 0.00178890161927
Men [popg] 0.00178114958482
Breast Cancer [neop] 0.00172164879347
Surgery [bmod] 0.00171972813394
reduction [npop] 0.00170538280011
baseline [bodm] 0.00170368841621
Statin [orch, phsu] 0.00168751257254
Survival [acty] 0.00168339452089
Health [idcn] 0.00165105504472
High Risk [qlco] 0.00164659518677
Primary [qlco] 0.00164213403075
Identified [qlco] 0.00162615011461
Prevention [topp] 0.00162331750366
risk factors [qnco] 0.00161704998929
Association [menp] 0.00161367019601
months [tmco] 0.00160876450184
Complications [patf] 0.00159920988877
Hazard Ratio [qnco] 0.00158936764506
Statins [orch, phsu] 0.00157382896017
Target [ftcn] 0.00156115308763
Evaluate [ftcn] 0.00153242998235
Specific [qlco] 0.00153090788225
Stroke [dsyn] 0.00149022323273
Reported [inpr] 0.00148274487876
interventions [hlca] 0.00148160064399
Reserve [acty] 0.00147615404551
Received [qlco] 0.00146923333394
Suggest [idcn] 0.00146638037336
Heart failure [dsyn] 0.00145870776841
Purpose [ftcn] 0.0014569477937
Benefit [qnco] 0.00145642787684
Odds Ratio [qnco] 0.00144458036123
Range [qnco] 0.00144398319138
Induced [ftcn] 0.00143603572948
Evaluated [ftcn] 0.00143060006112
Conduct [inbe] 0.0014145665807
Venous malformation [anab] 0.00138853057564
Cases [ftcn] 0.00138600881393
Heart [bpoc] 0.00138057967178
Radiation [npop] 0.00136847260828
GY [geoa] 0.00135849018079
Myocardial Infarction [dsyn] 0.00135228806442
condition [dsyn] 0.00134640865726
Irradiation [npop] 0.00134408304534
Current [tmco] 0.00133357662202
findings [ftcn] 0.00133194367614
Guidelines [inpr] 0.00131512600055
Observed [ftcn] 0.00130297483979
practice [menp] 0.00129835773248
Safety [hcpp] 0.00129584032419
Events [evnt] 0.00125450893741
Prognostic Factor [clna] 0.0012454820154
Therapeutic [topp] 0.00120583010128
Objective [inpr] 0.00120020950444
Levels [qlco] 0.0011969185268
Single [popg] 0.00119198871036
strategies [menp] 0.00119105821446
Blood Pressure [orgf] 0.00117096751611
Assessed [acty] 0.00116691818748
effective [qlco] 0.00116446102321
Improved [qlco] 0.00116039331935
Design [acty] 0.00115918165035
Adjusted [ftcn] 0.00115758048808
postmenopausal [tmco] 0.00115187967374
Subject [grup] 0.00114024412859
Children [aggp] 0.0011364141283
intervention [hlca] 0.00113604995458
Approach [spco] 0.00113341432066
placebo [topp] 0.00113213742618
Care [acty] 0.00112839081817
Need [qlco] 0.00111931342391
Reduced [qlco] 0.00111577794712
Sclerotherapy [topp] 0.00111224697373
PREVENT [phsu] 0.00111150549742
Improvement [cnce] 0.0011092986054
Atrial Fibrillation [patf] 0.00109396208011
Well [qlco] 0.00109202861377
Following [tmco] 0.00108937994926
IMPACT [gngm] 0.00108045704935
Life [idcn] 0.00106434799175
Effectiveness [qlco] 0.00104873870172
Hospital [hcro, mnob] 0.00104435482468
Index [inpr] 0.00104369843105
Limited [ftcn] 0.00104221184321
Elderly [popg] 0.00103590833452
Support [medd] 0.00102226048361
Main [qlco] 0.00101581371576
Independent [idcn] 0.00101397348169
Article [inpr] 0.00100752185032
Medications [phsu] 0.00100719610981
Metabolic syndrome [dsyn] 0.00100605850428
ischaemic heart disease [dsyn] 0.00100556486764
Needed [qlco] 0.00100517510289
Estimated [qnco] 0.00100104271112
Score [qnco] 0.0010003078364
Controlled [ftcn] 0.000999866309853
Hormone replacement therapy [topp] 0.000997831408899
Parameters [fndg] 0.000996246531125
Available [ftcn] 0.000995486954586
national [inpr] 0.00099284916045
experience [menp] 0.000991870391801
Comorbidities [idcn] 0.000980198183002
Measured [qlco] 0.000980126143763
People [popg] 0.00097141565824
Performed [ftcn] 0.000965469737321
Aged [orga] 0.000962657422076
Medication [phsu] 0.000961231421999
Drugs [phsu] 0.000959923164843
Multiple [qnco] 0.00095848280395
Diagnosed [fndg] 0.000957753854728
Atherosclerosis [dsyn] 0.00094493638876
Drug [phsu] 0.000939915845145
Novel [tmco] 0.000933345855553
Morbidity [qnco] 0.0009318076969
C-reactive protein [aapp, imft] 0.000927112413145
Large [qnco] 0.000914877526713
Long [qlco] 0.000913765028766
Receive [qlco] 0.000911155870073
Various [irda] 0.000907931409213
symptoms [ftcn] 0.000903809004004
patient care [hlca] 0.000902581718015
Often [tmco] 0.000895680615407
Increasing [ftcn] 0.00089031832205
Several [qnco] 0.00088349776693
Known [qlco] 0.000881638083709
Update [tmco] 0.00087663624691
function [phsf] 0.000865940335873
Defined [cnce] 0.000864711269795
Response [orga] 0.000855810080485
Assessment [hlca] 0.00084828793474
coronary [bpoc] 0.000845332583433
Aspirin [orch, phsu] 0.000840074112024
Complex [qlco] 0.000839367363159
Medical [ftcn] 0.00083358968858
Drug Therapy [topp] 0.000830315040926
Previous [tmco] 0.00082439501912
Lung [bpoc] 0.000823483857511
Relationship [qlco] 0.000822186201758
Bleeding [patf] 0.000809428686978
Androgen Deprivation Therapy [topp] 0.0008054225063
coronary artery disease [dsyn] 0.000804797693024
Dyslipidaemia [dsyn] 0.000801790983488
cardiovascular events [fndg] 0.000800883620782
Mechanisms [ftcn] 0.000799793990903
investigate [ftcn] 0.000798103462029
Literature [inpr] 0.00079481516997
Combination [qlco] 0.000794006588731
In [qnco] 0.000791313617712
setting [ftcn] 0.000790705803657
Cholesterol [bacs, strd] 0.000788807595347
Standard [qlco] 0.000787326575284
Life Style [socb] 0.000787154992635
Make [ftcn] 0.000786861792485
Menopause [phsf] 0.000784996089599
Chemotherapy [topp] 0.00078479053603
Evaluation [ftcn] 0.000784636984831
Process [bpoc] 0.000782981248396
Decreased [qnco] 0.000781686452059
Published [ocac] 0.000777060358529
free [ftcn] 0.000776576035326
Appropriate [qlco] 0.000776495242784
Survivors [podg] 0.000771005031659
vascular [bpoc] 0.000770433865703
Ratio [qnco] 0.000768401258921
Young [tmco] 0.000765882083602
Female [fndg] 0.000760597845999
Prostate Cancer [neop] 0.000757316566102
Lipid [lipd] 0.000756857477897
Alone [qnco] 0.000756312509426
Recommended [idcn] 0.000753156238199
Smoking [inbe] 0.000752899005997
Cardiovascular Diseases [dsyn] 0.000752362799012
objectives [inpr] 0.000751717494126
Ischaemic [ftcn] 0.000747623627858
Treatments [topp] 0.000747441150824
strategy [menp] 0.000746088486526
considered [idcn] 0.000746063528833
Comparison [acty] 0.000744370761364
System [ftcn] 0.000743650128985
Marker [clna] 0.000741850148698
Reducing [qlco] 0.000738206214599
Decrease [qlco] 0.000736595767766
search [inpr] 0.000733641735632
randomized [resa] 0.000730929825412
lesions [fndg] 0.000727742045071
reviewed [inpr] 0.000727571743781
Body Mass Index [diap] 0.000725917938503
Future [tmco] 0.000720316031561
acute [tmco] 0.00072029501718
Revealed [qlco] 0.000718202540821
Relevant [qlco] 0.000718147252084
Discharge [bdsu] 0.00071796180386
Severe [qlco] 0.000717456349152
Knowledge [inpr] 0.000716791944202
Head [blor] 0.0007160758369
cardiovascular risk factor [dsyn] 0.000715440227508
Pulmonary Hypertension [dsyn] 0.000713930679029
Work [ocac] 0.000711631616122
Associations [menp] 0.00071109428953
randomized controlled trials [inpr, resa] 0.000710243918811
Tool [mnob] 0.000708053235544
Combined [qlco] 0.000704725977066
Six [qnco] 0.000703763337677
Hold [idcn] 0.000702622124983
Take [hlca] 0.000701183247385
Heart disease [dsyn] 0.000696468366692
Plasma [bdsu] 0.000692342882181
Benefits [qnco] 0.000691072684093
Cardiology [bmod] 0.000689940640998
days [tmco] 0.000686110674226
prospective [resa] 0.000684975339735
Sex [orgf] 0.000681390210593
Optimal [qlco] 0.000680662681338
lowering [spco] 0.000678051738745
Improving [qlco] 0.00067291318631
Hospitalization [hlca] 0.000668323443203
Authors [prog] 0.000668157217283
Established [qlco] 0.000667862239282
Report [inpr] 0.000665356593117
Diseases [dsyn] 0.000664625791265
Likely [qlco] 0.000661629201495
Ageing [orgf] 0.000659681312304
LTD [ortf] 0.000657874734911
Leading [tmco] 0.000657076296312
radiation therapy [inpr] 0.000654798659046
adverse events [fndg] 0.00065398991354
Characteristics [qlco] 0.000652489527427
Cost Effectiveness [qnco] 0.000646624671973
Adult [aggp] 0.000645442128168
Searched [acty] 0.000642709611356
Strong [qlco] 0.000637061842176
Systolic blood pressure [clna] 0.000636013814089
Flow [npop] 0.000635746898855
Models [inpr] 0.000631463693489
Regression [patf] 0.000629522901657
Vascular Malformations [anab] 0.000628522123697
GIVEN [cnce] 0.000627768136887
prescribed [hlca] 0.000626071686093
Select [acty] 0.000625169921413
left sided [spco] 0.000624297024527
Issue [fndg] 0.000622476863416
Adults [aggp] 0.000622232325002
Global [spco] 0.000622021460965
Clinical Trials [resa] 0.000621133003608
Profile [lbpr] 0.000620900641627
Diabetes Mellitus [dsyn] 0.000620160529517
Review, Systematic [inpr] 0.000618829659637
Breast [bpoc] 0.000615092717692
Obesity [dsyn] 0.000613209320951
Additional [ftcn] 0.000610407543995
Occurred [acty] 0.000606212648818
Guide [prog] 0.000603772560721
Required [ftcn] 0.000599950558294
Measure [qnco] 0.000596682345086
Symptomatic [ftcn] 0.0005949177896
Decade [qnco] 0.000593630973639
History [ocdi] 0.000592879555772
Oral [spco] 0.0005913515298
chronic [tmco] 0.000591009404107
Test [lbpr] 0.000589646075737
American [popg] 0.000589499069391
Center [spco] 0.000587673617997
Few [qnco] 0.000587133429622
Currently [tmco] 0.000586731763048
Proportion [qnco] 0.000586095494855
Physicians [prog] 0.000584981918943
Addition [ftcn] 0.000584845538757
Program [cnce] 0.000583666097408
Database [inpr] 0.000582216790692
Lupus Erythematosus, Systemic [dsyn] 0.000579250882908
Adherence [ftcn] 0.000575409559548
Last [qlco] 0.000574705050897
activity [dora] 0.000571778260439
recommendations [idcn] 0.000571667128778
Comprehensive [qlco] 0.000570352664593
Estrogen [horm, phsu, strd] 0.000569880494221
Help [socb] 0.000569056072834
Doses [qnco] 0.000568811480612
Information [idcn] 0.000566893527816
Comorbidity [idcn] 0.000566880290384
criteria [inpr] 0.000566565291311
Physical activity [dora] 0.000566530358176
Agent [chvf] 0.000564181370192
Inflammatory [ftcn] 0.000563860157712
International [idcn] 0.000563701627203
atorvastatin [orch, phsu] 0.00055994140128
investigated [ftcn] 0.00055979817556
society [orgt] 0.000558146338385
Presented [idcn] 0.000556129420443
Fatal [qlco] 0.000555216368584
Understanding [menp] 0.000554922678327
deep breath [sosy] 0.000554281451556
Central [spco] 0.000554077572313
Small [qnco] 0.000553605774834
Technique [ftcn] 0.000551129193935
Represent [acty] 0.000551084267155
Stage [tmco] 0.000547315263349
Burden [idcn] 0.000546224149072
Risks [qlco] 0.000543785536899
Diet [food] 0.000543725283013
atherosclerotic [ftcn] 0.000543474815414
Myocardial [spco] 0.000542487770967
Provided [acty] 0.000540724216518
Secondary Prevention [topp] 0.000540290220085
size [spco] 0.000539900185878
Five [qnco] 0.00053948870794
Affect [menp] 0.000538689382456
Human [humn] 0.000532709987531
Good [qlco] 0.000532215162567
Favorable [qlco] 0.000531631542115
Post [tmco] 0.000531624759638
Countries [geoa] 0.000531606448209
Duration [tmco] 0.000531422690365
Damage [inpo] 0.000531275769587
Cost [qnco] 0.000527940734128
Examined [fndg] 0.000526451777724
Address [inpr] 0.00052565121761
Normal [qlco] 0.000525508327122
mice [mamm] 0.000523934073388
Postoperative [tmco] 0.000523690450649
Local [spco] 0.000522293710104
Average [qnco] 0.000520615332254
Inflammation [patf] 0.000520207954449
Exercise [dora] 0.000517798485403
Meta-Analysis [inpr] 0.000517407384415
Congenital heart disease [cgab, dsyn] 0.000517292543752
Confidence Intervals [qnco] 0.000516589025865
Died [orgf] 0.000514104031592
Prescription [hlca] 0.000514085773388
Elevated [qlco] 0.000512834746037
Gender [orga] 0.00051152275878
Pre-operative [tmco] 0.000511200051425
Risk Ratio [qnco] 0.000510644755513
Therapies [topp] 0.000510415974128
Control Group [grup] 0.000509893402401
Diagnostic [fndg] 0.000507722123355
Percutaneous Coronary Intervention [topp] 0.000507253137698
weeks [tmco] 0.000506834112961
Primary Care [hlca] 0.000504867437852
Applied [hlca] 0.000504774903905
deaths [orgf] 0.000503646223465
Obtained [ftcn] 0.000502915154671
Acute Coronary Syndrome [dsyn] 0.000497843213705
Challenge [clna] 0.000497736424846
Surgical [hlca] 0.000497102515872
Screening [hlca] 0.000496852829742
paediatric [bmod] 0.000496085284668
Calculated [ftcn] 0.000494313450702
Correlation [qlco] 0.000493254514931
incident [idcn] 0.000492587745677
Link [inpr] 0.000491920661584
Education [edac] 0.000488848161331
Daily [tmco] 0.00048800824657
European [popg] 0.000487830896034
Renal dysfunction [fndg] 0.0004856761372
Options [ftcn] 0.000484957962594
???lead [elii, hops] 0.000482936026818
Catheter Ablation [topp] 0.000482846862285
Values [qlco] 0.000482799476669
procedures [inpr] 0.000482479337129
Action [ftcn] 0.000482211982197
hypertensive [fndg] 0.000481184570654
Materials [sbst] 0.000480970693128
Sample [sbst] 0.000479881843974
side effects [ftcn] 0.000479100370305
Best [qlco] 0.000478220029171
Biomarkers [clna] 0.000478100781244
Record [inpr] 0.000477268114406
topic7
P NOS [aapp, imft] 0.0106825455395
treatment [ftcn] 0.0100857750943
Study [mnob] 0.00655783769118
Cardiovascular disease [dsyn] 0.00646787009509
Group [idcn] 0.00578917496285
Methods [inpr] 0.00452134152247
Women [popg] 0.00432575705883
Compared [acty] 0.00407105266338
Increased [qnco] 0.00384419645237
Mortality [qnco] 0.00359087983754
Trial [resa] 0.00341949479749
treated [topp] 0.00339669287027
Based [ftcn] 0.0033929811566
Age [orga] 0.00338225999993
Conclusions [idcn] 0.00329909544955
radiotherapy [inpr] 0.00320130598423
effects [qlco] 0.00306006012689
Dose [qnco] 0.00301096321905
Hypertension [dsyn] 0.00297709876087
included [ftcn] 0.00281425846951
Including [ftcn] 0.002773078685
CARDIOVASCULAR [bdsy] 0.00266323178989
therapy [ftcn] 0.00243170567938
Management [ocac] 0.0023698096354
participants [popg] 0.00235573776198
Health [idcn] 0.00224764141152
Men [popg] 0.00221929722113
Cardiac [bpoc] 0.00217880215061
Efficacy [qlco] 0.00217040177183
N NOS [aapp, imft] 0.00212876933002
Reported [inpr] 0.00211863868015
Care [acty] 0.00209573242302
months [tmco] 0.00208804108988
Diabetes [dsyn] 0.00203053750411
Statin [orch, phsu] 0.00193368184304
Identified [qlco] 0.00191003792463
Surgery [bmod] 0.00186760876848
Cases [ftcn] 0.00182737596068
Association [menp] 0.00182285161903
Quality [qlco] 0.00182221538442
Heart [bpoc] 0.00176926849185
Prevention [topp] 0.00172955761616
Survival [acty] 0.00172454538632
Primary [qlco] 0.00166025227796
GY [geoa] 0.00165885301046
Stroke [dsyn] 0.00164881628096
cardiovascular events [fndg] 0.0016329364523
risk factors [qnco] 0.00160264443052
baseline [bodm] 0.00160208628994
Sclerotherapy [topp] 0.00159474562553
People [popg] 0.00158022268101
Old [tmco] 0.0015705197402
Odds Ratio [qnco] 0.001565163374
Suggest [idcn] 0.0015531016627
Breast Cancer [neop] 0.00155069604192
Evaluated [ftcn] 0.00154369544832
Need [qlco] 0.00154041069956
Specific [qlco] 0.00151998414439
Statins [orch, phsu] 0.0015117172147
Observed [ftcn] 0.00150179365347
Reduced [qlco] 0.00148294607777
Heart failure [dsyn] 0.00147375312247
Present [qnco] 0.00145089985605
effective [qlco] 0.00144790113715
Response [orga] 0.00144486683387
Target [ftcn] 0.00144325025459
Purpose [ftcn] 0.00141684996212
Subject [grup] 0.00141407680323
coronary heart disease [dsyn] 0.00139411762232
Blood Pressure [orgf] 0.00139178068895
reduction [npop] 0.00138574056829
condition [dsyn] 0.00137446478472
intervention [hlca] 0.00136961056082
Assessed [acty] 0.00135527357225
IMPACT [gngm] 0.00134329297124
Objective [inpr] 0.00133818514949
Range [qnco] 0.00133670985449
Medications [phsu] 0.0013224026163
Venous malformation [anab] 0.00131586675895
Reserve [acty] 0.00128932888877
Therapeutic [topp] 0.00128084969325
Conduct [inbe] 0.0012790046074
Evaluate [ftcn] 0.00126776635795
Drug [phsu] 0.0012510690398
Decreased [qnco] 0.00123310273118
findings [ftcn] 0.00123205464751
Controlled [ftcn] 0.00123142865794
Performed [ftcn] 0.00122839193717
coronary artery disease [dsyn] 0.00122553772158
search [inpr] 0.00120104262103
Current [tmco] 0.00119226022108
Radiation [npop] 0.00118533531768
Published [ocac] 0.00117239956431
Myocardial Infarction [dsyn] 0.00117033739126
Receive [qlco] 0.00116398328425
interventions [hlca] 0.00115654371662
Life [idcn] 0.00115621621941
Children [aggp] 0.00115380814699
placebo [topp] 0.0011475206565
Levels [qlco] 0.00113440386366
Drugs [phsu] 0.00112090177487
Defined [cnce] 0.00110970230447
Events [evnt] 0.00110246812682
Adjusted [ftcn] 0.00109968142594
Benefit [qnco] 0.00109775503904
Induced [ftcn] 0.00109445621806
Prognostic Factor [clna] 0.00108930024039
Several [qnco] 0.00107027392771
Hazard Ratio [qnco] 0.00106863100774
Future [tmco] 0.00106437494033
Decrease [qlco] 0.00105164380302
High Risk [qlco] 0.00105034333367
Often [tmco] 0.00104750403704
Available [ftcn] 0.00104583010236
Severe [qlco] 0.00103883273528
Diagnosed [fndg] 0.00103413027175
national [inpr] 0.00101833503918
Hormone replacement therapy [topp] 0.0010182293219
Medication [phsu] 0.00101146604831
Comorbidities [idcn] 0.00101042237933
Main [qlco] 0.0010086666981
Improvement [cnce] 0.0010064449898
postmenopausal [tmco] 0.00100352800264
Effectiveness [qlco] 0.00100160461855
Ratio [qnco] 0.00100013480286
objectives [inpr] 0.00100007625214
Hospital [hcro, mnob] 0.000999916327695
Irradiation [npop] 0.000998495559635
Complications [patf] 0.000991973386515
practice [menp] 0.000990788439502
Improved [qlco] 0.000990745798614
Increasing [ftcn] 0.000983295438301
Lipid [lipd] 0.000979037382761
Large [qnco] 0.000977559808018
Relationship [qlco] 0.000973820207133
Following [tmco] 0.00096734382978
patient care [hlca] 0.000960201336108
Aspirin [orch, phsu] 0.00095786766161
Article [inpr] 0.000953571162694
Information [idcn] 0.000934176890447
mmHg [qnco] 0.000933643031183
Adult [aggp] 0.000930524966837
Complex [qlco] 0.000923113458783
Optimal [qlco] 0.000918905461933
PREVENT [phsu] 0.000917568975971
days [tmco] 0.000916169523966
Design [acty] 0.000914026297615
Approach [spco] 0.000912555573841
System [ftcn] 0.00090241833044
Metabolic syndrome [dsyn] 0.000900220663606
Multiple [qnco] 0.00088965751571
Drug Therapy [topp] 0.000882850220154
Five [qnco] 0.000882429490515
Smoking [inbe] 0.000881248734526
Safety [hcpp] 0.000879170884081
ischaemic heart disease [dsyn] 0.000868482538477
Guidelines [inpr] 0.000866066498844
Atrial Fibrillation [patf] 0.000864585632808
vascular [bpoc] 0.000864449152936
Atherosclerosis [dsyn] 0.000864029277654
Estimated [qnco] 0.000861915986963
experience [menp] 0.000859912539069
Received [qlco] 0.000859763803587
Known [qlco] 0.000855939032079
Young [tmco] 0.000851258504716
Make [ftcn] 0.000847125677017
Independent [idcn] 0.000846054854761
Limited [ftcn] 0.000844149529216
Measured [qlco] 0.00083349138677
Authors [prog] 0.000829654038898
Needed [qlco] 0.000827327635935
Various [irda] 0.000826315961506
Androgen Deprivation Therapy [topp] 0.000821921388328
strategies [menp] 0.000821505220295
Select [acty] 0.000820094394818
Diseases [dsyn] 0.000816346017819
Well [qlco] 0.000814295154422
Confidence Intervals [qnco] 0.000809197697202
Small [qnco] 0.000808713970792
Combination [qlco] 0.000804671497817
symptoms [ftcn] 0.000798007179037
Update [tmco] 0.00078973509348
Cardiovascular Diseases [dsyn] 0.000789409423654
Risk Ratio [qnco] 0.000787391537354
Female [fndg] 0.000787052206318
LTD [ortf] 0.000786429210428
adverse events [fndg] 0.000786411512513
Searched [acty] 0.000784304323275
Oral [spco] 0.000784058208577
Address [inpr] 0.000780951153636
Additional [ftcn] 0.000780731031503
Elderly [popg] 0.000780693762419
Heart disease [dsyn] 0.000780507075673
Survivors [podg] 0.0007802823372
Index [inpr] 0.000780044935906
Breast [bpoc] 0.00077850242868
Characteristics [qlco] 0.000773924544398
Menopause [phsf] 0.000768149711893
Aged [orga] 0.000762593682907
Assessment [hlca] 0.000761460748417
Functional [ftcn] 0.000755972721482
Guide [prog] 0.000751425166436
prognostic [inpr] 0.000750654644029
Evaluation [ftcn] 0.000749891654483
Morbidity [qnco] 0.000749243040369
Review, Systematic [inpr] 0.000748732427482
Represent [acty] 0.000748527569509
Addition [ftcn] 0.000747765130737
Meta-Analysis [inpr] 0.00074710230393
strategy [menp] 0.000746089207316
Chemotherapy [topp] 0.000743924684718
Screening [hlca] 0.000741767633916
acute [tmco] 0.000741363218739
Second [qnco] 0.000739468110126
Reducing [qlco] 0.000739259200872
investigate [ftcn] 0.000737311518016
Profile [lbpr] 0.000731544288311
Clinical Trials [resa] 0.000731269986372
Discharge [bdsu] 0.000729084487151
chronic [tmco] 0.000728209621542
Sex [orgf] 0.000727437517581
Combined [qlco] 0.000722677375757
deep breath [sosy] 0.00072030765468
GIVEN [cnce] 0.000720106813212
Associations [menp] 0.000718447892801
Physicians [prog] 0.000716174096766
Knowledge [inpr] 0.000716154296486
function [phsf] 0.000711791332039
randomized [resa] 0.000711395800011
setting [ftcn] 0.000709858884204
Mechanisms [ftcn] 0.000709364276277
Long [qlco] 0.000707139881343
Parameters [fndg] 0.000705665946089
Support [medd] 0.000705341093663
History [ocdi] 0.000702189310415
Tool [mnob] 0.000701836219278
Leading [tmco] 0.000699702238971
Cost [qnco] 0.000698698884387
Congenital heart disease [cgab, dsyn] 0.000696927641602
side effects [ftcn] 0.000692326728772
Treatments [topp] 0.000692034733752
Single [popg] 0.000687630659753
Bleeding [patf] 0.000685744344425
Novel [tmco] 0.000681873003875
Marker [clna] 0.000681703923061
Six [qnco] 0.000670957337409
Medical [ftcn] 0.000668938788159
C-reactive protein [aapp, imft] 0.000666452740866
Exercise [dora] 0.000666022711997
Pulmonary Hypertension [dsyn] 0.000663869961281
Neck [blor] 0.000663170118682
Post [tmco] 0.000661854674533
reviewed [inpr] 0.000661643669073
Help [socb] 0.000659486950595
Program [cnce] 0.000659003953094
APPEAR [qlco] 0.000658138081753
Obesity [dsyn] 0.000657846173426
Occurred [acty] 0.000657450092771
Burden [idcn] 0.000654735562916
Hold [idcn] 0.00065083097451
Decade [qnco] 0.000648037051583
Understanding [menp] 0.00064719979235
lesions [fndg] 0.000646368304488
Lung [bpoc] 0.000645890088158
Likely [qlco] 0.000645841280906
Last [qlco] 0.000645779204491
Primary Care [hlca] 0.000645402933731
Chronic kidney disease [dsyn] 0.000644435667687
Score [qnco] 0.000640326662655
Stage [tmco] 0.000639205970168
Obtained [ftcn] 0.00063674348276
Appropriate [qlco] 0.000636634748424
Fatal [qlco] 0.000630090088582
Magnetic Resonance Imaging [diap] 0.000629413382556
Adults [aggp] 0.000628360445581
Collected [idcn] 0.000626956275562
Examined [fndg] 0.00062568575264
Center [spco] 0.000624988294808
radiation therapy [inpr] 0.000624613972224
Dyslipidaemia [dsyn] 0.000623626715659
Literature [inpr] 0.000620284170143
Polypharmacy [fndg] 0.000619276829047
Estrogen [horm, phsu, strd] 0.000617675097354
Biomarkers [clna] 0.000616075527538
Human [humn] 0.000615553810252
Database [inpr] 0.000615314772134
Cholesterol [bacs, strd] 0.000611226164442
criteria [inpr] 0.000609530605799
Recommended [idcn] 0.000608864869702
heart rate [clna] 0.000607629372412
Test [lbpr] 0.000607396853579
Comorbidity [idcn] 0.000603941510322
Cost Effectiveness [qnco] 0.000602602277523
Alone [qnco] 0.000601804516622
Values [qlco] 0.000598555504293
prescribed [hlca] 0.000596537348061
weeks [tmco] 0.000596263125283
Relevant [qlco] 0.000593513547455
Prostate Cancer [neop] 0.000593200563278
Challenge [clna] 0.000592134140604
Standard [qlco] 0.000591796420809
Symptomatic [ftcn] 0.000591059224373
mice [mamm] 0.000589875779878
society [orgt] 0.000589342644671
Issue [fndg] 0.000588601156723
Flow [npop] 0.00058783414575
Percutaneous Coronary Intervention [topp] 0.000585438479581
Body Mass Index [diap] 0.000584171973474
Late [tmco] 0.000584121561404
Report [inpr] 0.000583536022621
Imaging [diap] 0.000582621481211
Regression [patf] 0.000582421166463
Agent [chvf] 0.000581366713734
Moderate [qlco] 0.000578142545743
Ischaemic stroke [dsyn] 0.000576791773117
considered [idcn] 0.000576713526088
Plasma [bdsu] 0.000574733210879
Diet [food] 0.00057171807968
Involving [ftcn] 0.000571485712063
Benefits [qnco] 0.000566490389327
Ageing [orgf] 0.00056421977748
Good [qlco] 0.000560958546006
Relative [famg] 0.000560181638027
Exposure NOS [inpo] 0.000559405072319
Take [hlca] 0.000557801673992
Physical activity [dora] 0.00055666409228
variables [qlco] 0.000556423005697
Hospitalization [hlca] 0.00055625496771
Strong [qlco] 0.000556175426765
Surgical [hlca] 0.000554149676366
secondary [neop] 0.000554014227621
left sided [spco] 0.000553157595617
randomized controlled trials [inpr, resa] 0.000551231192133
Interaction [ftcn] 0.0005509009414
Bias [idcn] 0.00054844725838
Age-Years [tmco] 0.000546203117386
Head [blor] 0.000542401931713
procedures [inpr] 0.000542367036065
Revealed [qlco] 0.000542159634501
lowering [spco] 0.00054199591409
Low Risk [fndg] 0.000540674411772
Comparison [acty] 0.000540081868152
If [qlco] 0.000539631612075
Acute Coronary Syndrome [dsyn] 0.000538864045545
Inflammatory [ftcn] 0.000535071792568
investigated [ftcn] 0.000531285386022
Non-Small Cell Lung Cancer [neop] 0.00053020048469
Normal [qlco] 0.000529053669466
Diabetes Mellitus [dsyn] 0.000527262309811
Affect [menp] 0.000526937395406
Hodgkin Lymphoma [neop] 0.000526478854014
In [qnco] 0.000524668071063
atherosclerotic [ftcn] 0.000524261091351
Proportion [qnco] 0.000522460428033
Depression [mobd] 0.000521916975699
Education [edac] 0.000521047589203
paediatric [bmod] 0.00052022279991
Improving [qlco] 0.000519470438648
With [qlco] 0.000517917993584
International [idcn] 0.000517391850517
Secondary Prevention [topp] 0.000517134327943
Duration [tmco] 0.000516446215553
Inflammation [patf] 0.000514993704665
Correlation [qlco] 0.000514479774852
atorvastatin [orch, phsu] 0.000513482146777
free [ftcn] 0.000512671631148
Postoperative [tmco] 0.000509664112013
Risks [qlco] 0.000508402591773
Diagnostic [fndg] 0.000508401525451
Required [ftcn] 0.000506431628651
Survey [inpr] 0.000505177196553
Daily [tmco] 0.000500760719195
Gender [orga] 0.000500319126531
Damage [inpo] 0.0004987171231
Then [tmco] 0.00049810710623
lack [qlco] 0.000495940455796
Presented [idcn] 0.000493767946746
deaths [orgf] 0.000493717648134
Life Style [socb] 0.000493517796705
prospective [resa] 0.000493495123371
Adherence [ftcn] 0.000491748562233
Non-alcoholic Fatty Liver Disease [dsyn] 0.000491738255896
Out [spco] 0.000490050936297
Play [dora] 0.000489668512585
PLAN [dsyn] 0.000489121399575
size [spco] 0.00048637126548
Prescription [hlca] 0.000486340983637
Link [inpr] 0.000484553518425
Ischaemic [ftcn] 0.000483702472309
Focus [spco] 0.000483168766086
Venous Thromboembolism [patf] 0.000481349632113
Work [ocac] 0.000481005330059
Applied [hlca] 0.00048010190865
Estimate [qnco] 0.000480080590851
Inspiration [orgf] 0.000479176272032
Acute myocardial infarction [dsyn] 0.000474484998647
Process [bpoc] 0.000472886319965
Doses [qnco] 0.000472852244544
Of [spco] 0.000472016629238
Systolic blood pressure [clna] 0.000470941010521
topic8
P NOS [aapp, imft] 0.00982435499703
treatment [ftcn] 0.00819848749381
Study [mnob] 0.00774376252676
Group [idcn] 0.00649604233807
Women [popg] 0.00645988390774
Cardiovascular disease [dsyn] 0.00563104996823
Trial [resa] 0.0044778269245
Mortality [qnco] 0.00433738178449
CARDIOVASCULAR [bdsy] 0.00431590423574
Age [orga] 0.00417990016249
Compared [acty] 0.00387093356104
Methods [inpr] 0.00376009305174
included [ftcn] 0.00347498896664
Including [ftcn] 0.0031682235637
Increased [qnco] 0.0031537882034
Based [ftcn] 0.00305467559467
Hypertension [dsyn] 0.0028129496794
Heart [bpoc] 0.00277741019484
therapy [ftcn] 0.00276627935763
Conclusions [idcn] 0.0027527455196
Dose [qnco] 0.00270628759871
Survival [acty] 0.00265704902295
months [tmco] 0.00257778892878
treated [topp] 0.00252920566987
participants [popg] 0.00247901348309
radiotherapy [inpr] 0.00243265314994
Men [popg] 0.00243203956811
Health [idcn] 0.00218096055919
risk factors [qnco] 0.00217639885841
Diabetes [dsyn] 0.00216547777971
Complications [patf] 0.0021320491775
Cardiac [bpoc] 0.0020810329074
Care [acty] 0.00199913237455
Management [ocac] 0.00192196598018
Performed [ftcn] 0.00188536920342
Old [tmco] 0.00187097849126
IMPACT [gngm] 0.00186810753397
Suggest [idcn] 0.00186758627136
effects [qlco] 0.00185861612575
Heart failure [dsyn] 0.00185493562225
Reduced [qlco] 0.0018532433165
Stroke [dsyn] 0.00183804221433
Cases [ftcn] 0.00182411707117
Association [menp] 0.00181482559643
Breast Cancer [neop] 0.00178980496274
Induced [ftcn] 0.00176289948692
N NOS [aapp, imft] 0.00173424750409
Prevention [topp] 0.00171920198216
High Risk [qlco] 0.00171556016878
Statins [orch, phsu] 0.00165175027513
Drugs [phsu] 0.00164957133635
Quality [qlco] 0.00162689696004
Hazard Ratio [qnco] 0.00159930730356
Evaluate [ftcn] 0.00158411464106
Present [qnco] 0.00156125284093
baseline [bodm] 0.00156037657874
Reserve [acty] 0.00155541797933
Surgery [bmod] 0.00155442535743
Primary [qlco] 0.00154556539842
Current [tmco] 0.00154042455771
Guidelines [inpr] 0.00149188217721
coronary heart disease [dsyn] 0.00149178898185
vascular [bpoc] 0.00148527863692
Reported [inpr] 0.00148121174414
Odds Ratio [qnco] 0.00146995067791
Observed [ftcn] 0.00146616686755
Evaluated [ftcn] 0.00146321797483
Need [qlco] 0.00146180879719
findings [ftcn] 0.00145744139752
Levels [qlco] 0.00140176395967
Statin [orch, phsu] 0.00140141970499
Target [ftcn] 0.00139555397567
Drug [phsu] 0.00138869274887
reduction [npop] 0.00136565963878
effective [qlco] 0.00135565871248
Information [idcn] 0.0013357735067
postmenopausal [tmco] 0.00131648585851
Following [tmco] 0.00131487595013
Effectiveness [qlco] 0.00129145998651
Efficacy [qlco] 0.00128390618389
Improvement [cnce] 0.00127964092795
Range [qnco] 0.00127330800973
Assessed [acty] 0.00125719561957
Blood Pressure [orgf] 0.00124480343262
Purpose [ftcn] 0.00123633970378
Received [qlco] 0.00122399136237
Specific [qlco] 0.00122125006636
Safety [hcpp] 0.00122123466982
Identified [qlco] 0.00120717914364
Score [qnco] 0.00119807181712
Sclerotherapy [topp] 0.00119478167576
Index [inpr] 0.00118213336764
Events [evnt] 0.00116918107619
Improved [qlco] 0.00116445917497
Approach [spco] 0.00115414197559
Therapeutic [topp] 0.00115312721113
Radiation [npop] 0.00114811668677
coronary artery disease [dsyn] 0.00114545814997
Children [aggp] 0.00114343153623
Benefit [qnco] 0.00113678795734
Several [qnco] 0.00113056606626
Available [ftcn] 0.00112512870204
Hormone replacement therapy [topp] 0.00110869268351
GY [geoa] 0.00110129910422
Receive [qlco] 0.00109090072898
Published [ocac] 0.00108945235548
Irradiation [npop] 0.00107954441115
cardiovascular events [fndg] 0.00107921752808
People [popg] 0.00107732499657
Adjusted [ftcn] 0.00107018381749
Main [qlco] 0.00105858996774
PREVENT [phsu] 0.00105292672982
Needed [qlco] 0.00104923950439
strategies [menp] 0.00104620909583
Decreased [qnco] 0.00103446662311
Diagnosed [fndg] 0.00103379504022
Measured [qlco] 0.00103330740241
Atherosclerosis [dsyn] 0.00102327468665
Objective [inpr] 0.00101981254341
Subject [grup] 0.00101110693259
Drug Therapy [topp] 0.00100982484689
Young [tmco] 0.00100295668678
interventions [hlca] 0.00100108067004
function [phsf] 0.00100036116762
Metabolic syndrome [dsyn] 0.000995634342277
Atrial Fibrillation [patf] 0.000994485365095
placebo [topp] 0.000986337852325
considered [idcn] 0.000978712162704
setting [ftcn] 0.000974548716833
Acute Coronary Syndrome [dsyn] 0.000974207200954
Authors [prog] 0.000963748219995
condition [dsyn] 0.000963367187027
Medication [phsu] 0.000963018559257
Estimated [qnco] 0.000958134683022
Well [qlco] 0.000953129367495
intervention [hlca] 0.000950941427398
Complex [qlco] 0.000949616074984
Inspiration [orgf] 0.000941401588193
objectives [inpr] 0.000933928376266
Profile [lbpr] 0.000925291908665
Myocardial Infarction [dsyn] 0.000924007024026
Hospital [hcro, mnob] 0.000923882192399
Aged [orga] 0.000922709817688
patient care [hlca] 0.000921119095218
Update [tmco] 0.000914650548404
acute [tmco] 0.000911143271463
Prognostic Factor [clna] 0.00091062173188
Large [qnco] 0.000906816904756
Life [idcn] 0.000906670970605
Medications [phsu] 0.000905006955689
Limited [ftcn] 0.000900123637073
Evaluation [ftcn] 0.000894863452181
Comorbidities [idcn] 0.000892266111827
practice [menp] 0.000886050520635
Increasing [ftcn] 0.000885960130965
search [inpr] 0.000883420530027
Understanding [menp] 0.000879067952766
Decrease [qlco] 0.000878227336772
Design [acty] 0.000875812491907
Venous malformation [anab] 0.000871893447656
radiation therapy [inpr] 0.000865645456304
days [tmco] 0.000861987593773
Severe [qlco] 0.000860493415111
experience [menp] 0.000855788517647
Make [ftcn] 0.00085279043341
Take [hlca] 0.000852087148001
Medical [ftcn] 0.000851446039767
Obesity [dsyn] 0.00085040975218
investigated [ftcn] 0.0008480782025
Known [qlco] 0.000835755709879
Prostate Cancer [neop] 0.000832514336625
ischaemic heart disease [dsyn] 0.000829375188628
Chronic kidney disease [dsyn] 0.000824804677288
Hold [idcn] 0.00082468635517
Future [tmco] 0.000824397235085
Mechanisms [ftcn] 0.000824117871581
Various [irda] 0.000823786079084
Five [qnco] 0.000822392596494
society [orgt] 0.000819660070595
Average [qnco] 0.000815509984397
Burden [idcn] 0.000811225651833
Polypharmacy [fndg] 0.000810335356272
Morbidity [qnco] 0.000809292277734
Breast [bpoc] 0.000808610510567
Affect [menp] 0.000807740360125
Appropriate [qlco] 0.000806276738281
randomized [resa] 0.000803903683584
LTD [ortf] 0.000803521547884
Combined [qlco] 0.000801316147406
Support [medd] 0.000800255031135
Aspirin [orch, phsu] 0.000800235044346
Characteristics [qlco] 0.000794747201102
free [ftcn] 0.000793932516828
Life Style [socb] 0.000792820661689
Multiple [qnco] 0.000792309353593
heart rate [clna] 0.000791423793662
Comparison [acty] 0.000788454577876
Report [inpr] 0.000786061098519
Response [orga] 0.000780237458462
Sex [orgf] 0.00077706524849
mmHg [qnco] 0.000776940022099
Diseases [dsyn] 0.000769342729986
lowering [spco] 0.000767484787082
Knowledge [inpr] 0.000763822931719
Benefits [qnco] 0.000762320971423
activity [dora] 0.000761747322967
Six [qnco] 0.000761560994345
recommendations [idcn] 0.000760286850334
Long [qlco] 0.000759578006355
Challenge [clna] 0.000759293112661
Estrogen [horm, phsu, strd] 0.000758303255009
Heart disease [dsyn] 0.000754744258456
Smoking [inbe] 0.000752925837287
Diet [food] 0.000750933967173
Occurred [acty] 0.000746898512811
Oral [spco] 0.000742147487598
System [ftcn] 0.000741486955163
coronary [bpoc] 0.000740468415068
Single [popg] 0.000737119176207
Examined [fndg] 0.000736147242302
Parameters [fndg] 0.00073556626565
Independent [idcn] 0.000733687153403
symptoms [ftcn] 0.000730231903993
Last [qlco] 0.000728892561097
Cholesterol [bacs, strd] 0.000721597920075
Adult [aggp] 0.000719254205955
Treatments [topp] 0.000719169657188
Reducing [qlco] 0.000716830890546
Center [spco] 0.000712416077632
Dyslipidaemia [dsyn] 0.000712181338208
Addition [ftcn] 0.000711936055465
Ratio [qnco] 0.00071113359185
left sided [spco] 0.000709450195017
Pulmonary Hypertension [dsyn] 0.000709046360534
Adherence [ftcn] 0.000703318616347
Optimal [qlco] 0.000701577174154
Cost Effectiveness [qnco] 0.000701552835123
Small [qnco] 0.000695441588413
Normal [qlco] 0.000691728549613
Recommended [idcn] 0.000689983453875
deep breath [sosy] 0.000685111622044
Surgical [hlca] 0.000680999263441
Conduct [inbe] 0.000680827626543
Provided [acty] 0.000680417825292
Defined [cnce] 0.000676568496479
Imaging [diap] 0.000675158480542
lesions [fndg] 0.000670317998741
investigate [ftcn] 0.000669558884099
Survivors [podg] 0.000667839890479
Adults [aggp] 0.000667224592005
Biomarkers [clna] 0.000666193741287
Novel [tmco] 0.000665095203707
Procedure [diap, topp] 0.000662448704654
side effects [ftcn] 0.000660788562147
Exercise [dora] 0.000660559705653
Literature [inpr] 0.000659643188154
weeks [tmco] 0.000658928845663
Article [inpr] 0.000655779241432
Tool [mnob] 0.000653412965944
national [inpr] 0.000650561316061
Physical activity [dora] 0.000650166854533
Agent [chvf] 0.000649069803985
Address [inpr] 0.000644553742799
Late [tmco] 0.000643544965412
Meta-Analysis [inpr] 0.000640937214182
Menopause [phsf] 0.000640748183352
Plasma [bdsu] 0.000640074151834
criteria [inpr] 0.000638771485638
strategy [menp] 0.000637966490302
Cost [qnco] 0.000637613677921
History [ocdi] 0.000637535591387
Program [cnce] 0.000634180810725
Moderate [qlco] 0.000632272208971
Stage [tmco] 0.000631611780002
Review, Systematic [inpr] 0.000630494590528
Depression [mobd] 0.000630491988631
Often [tmco] 0.000629180142398
C-reactive protein [aapp, imft] 0.000628142350108
Assessment [hlca] 0.000627040075652
Guide [prog] 0.000625268632219
Select [acty] 0.000624966753277
Approaches [spco] 0.000621496815493
Chemotherapy [topp] 0.000619691755819
prescribed [hlca] 0.000618913449419
In [qnco] 0.000614907288672
Relevant [qlco] 0.000613724373209
Clinical Trials [resa] 0.000610194938301
Female [fndg] 0.000609368114342
Symptomatic [ftcn] 0.000607854532575
Elderly [popg] 0.000605019469458
atorvastatin [orch, phsu] 0.000604133482262
Screening [hlca] 0.000599382552554
Combination [qlco] 0.000598838600105
Discharge [bdsu] 0.000597399585185
Focus [spco] 0.000596759071209
Previous [tmco] 0.000595848540539
Searched [acty] 0.000593789825462
Lipid [lipd] 0.000593734598927
Leading [tmco] 0.000593185311337
randomized controlled trials [inpr, resa] 0.000592109730561
Improving [qlco] 0.000585291525313
Inflammatory [ftcn] 0.000583587679643
Duration [tmco] 0.000582571175196
Marker [clna] 0.00058232772184
Body Mass Index [diap] 0.000579677748983
GIVEN [cnce] 0.000578491870285
Additional [ftcn] 0.000577308566746
Controlled [ftcn] 0.000577006901646
Confidence Intervals [qnco] 0.000576083095044
Advance [medd] 0.000571895725959
Help [socb] 0.000570771331634
Cardiovascular Diseases [dsyn] 0.000570254485715
Part [spco] 0.000569917600145
Primary Care [hlca] 0.0005688110827
Materials [sbst] 0.000568027970917
Represent [acty] 0.000566826324208
Diagnostic [fndg] 0.000566166721918
Local [spco] 0.000566141487731
reviewed [inpr] 0.000562349132779
Measure [qnco] 0.000559206927248
Androgen Deprivation Therapy [topp] 0.000558243592363
Second [qnco] 0.000557659054925
secondary [neop] 0.000557406792159
Database [inpr] 0.000557347038255
Postoperative [tmco] 0.000556967632102
techniques [inpr] 0.000556909350537
Process [bpoc] 0.000556585512049
Doses [qnco] 0.000555331207488
paediatric [bmod] 0.000554216912576
Applied [hlca] 0.00055195524029
Ischaemic stroke [dsyn] 0.000551536790613
Alone [qnco] 0.000551142350351
atherosclerotic [ftcn] 0.000550021104896
Issue [fndg] 0.000545186653122
Currently [tmco] 0.000543788370599
Cardiology [bmod] 0.000542472914277
Revealed [qlco] 0.000542397960425
Magnetic Resonance Imaging [diap] 0.000539536011987
Good [qlco] 0.000538258634281
Standard [qlco] 0.000537990109477
Likely [qlco] 0.000537019895038
Risks [qlco] 0.000536702772294
???lead [elii, hops] 0.000534614809333
Functional [ftcn] 0.000532343857802
Few [qnco] 0.000531538461539
Proportion [qnco] 0.000531309666061
Head [blor] 0.000529029116155
Bleeding [patf] 0.000527305627776
Interaction [ftcn] 0.000526786568402
Countries [geoa] 0.000524879631281
Concern [idcn] 0.000523270231383
Obtained [ftcn] 0.000523220248968
Established [qlco] 0.000522067086772
High dose [qnco] 0.000521360111702
European [popg] 0.000519014503202
Fatal [qlco] 0.000517746995481
APPEAR [qlco] 0.000516655837977
Bias [idcn] 0.000514460339853
Administration [ocac] 0.000514075942504
Associations [menp] 0.000513805241252
cardiovascular risk factor [dsyn] 0.00051371392562
Decade [qnco] 0.000512390761744
Regression [patf] 0.000511420980132
Pulmonary arterial hypertension [dsyn] 0.00051038487259
lack [qlco] 0.000508955476133
Lung [bpoc] 0.00050598175786
Ethanol [orch] 0.000505459477228
prognostic [inpr] 0.000504778813148
Congenital heart disease [cgab, dsyn] 0.000503736828601
Daily [tmco] 0.000501684007703
Prescription [hlca] 0.000500560762678
Ischaemic [ftcn] 0.000500388907762
progression [patf] 0.00050006495184
Values [qlco] 0.000500011497904
Obese [dsyn] 0.000498724961003
size [spco] 0.000496916910024
Very [qlco] 0.000495973523996
Dependent [qlco] 0.000495073625576
Best [qlco] 0.000493740990141
Seven [qnco] 0.000491463910177
Effort [orgf] 0.000491062392886
Global [spco] 0.000490531688598
Area [geoa] 0.000490238721656
Low Risk [fndg] 0.000487780628634
Vascular Malformations [anab] 0.000486456834327
Work [ocac] 0.000486382144344
Consecutive [qlco] 0.000485151232241
Strong [qlco] 0.00048214559924
Neck [blor] 0.000482081422789
Percutaneous Coronary Intervention [topp] 0.000481457697877
Collected [idcn] 0.000480564925573
Correlation [qlco] 0.000480137647674
majority [socb] 0.000479973472562
Gender [orga] 0.000478852409337
chronic [tmco] 0.000478260478738
Calculated [ftcn] 0.000477240238028
Required [ftcn] 0.000476658734333
Comorbidity [idcn] 0.000475985400058
Diabetes Mellitus [dsyn] 0.000475934208419
Systolic blood pressure [clna] 0.000473777390846
topic9
P NOS [aapp, imft] 0.0105536296613
Study [mnob] 0.00749622487131
treatment [ftcn] 0.00735114664181
Cardiovascular disease [dsyn] 0.00615155079877
Mortality [qnco] 0.00574456431051
Group [idcn] 0.00515300324294
Methods [inpr] 0.00491831114556
Women [popg] 0.00442240925579
Conclusions [idcn] 0.00442136419281
Based [ftcn] 0.00390713224018
CARDIOVASCULAR [bdsy] 0.00385035731633
Trial [resa] 0.0033041644254
effects [qlco] 0.003240877113
Age [orga] 0.00312652039262
included [ftcn] 0.00307619001096
Hypertension [dsyn] 0.00279934445996
Increased [qnco] 0.0027905819952
radiotherapy [inpr] 0.00258496140826
participants [popg] 0.00251407869065
Men [popg] 0.00246298612707
Including [ftcn] 0.00245130347883
Diabetes [dsyn] 0.00241441221667
Management [ocac] 0.0023819162657
therapy [ftcn] 0.00236459110839
Health [idcn] 0.00232246084237
Survival [acty] 0.00229009356025
Old [tmco] 0.00224818521289
treated [topp] 0.00218949274088
Compared [acty] 0.00217796399281
Efficacy [qlco] 0.00217514416553
Present [qnco] 0.00216917749011
Breast Cancer [neop] 0.00214872544902
Dose [qnco] 0.00209376104973
N NOS [aapp, imft] 0.00201913220319
Odds Ratio [qnco] 0.00195198447157
Reduced [qlco] 0.00193270871168
Cardiac [bpoc] 0.00193111955038
Stroke [dsyn] 0.00190678431856
Association [menp] 0.00188322483544
months [tmco] 0.00187788792076
Reported [inpr] 0.00187634607583
Surgery [bmod] 0.00183529158287
Target [ftcn] 0.00182114569003
Reserve [acty] 0.00175550718473
Specific [qlco] 0.00173752949353
Induced [ftcn] 0.00169152834211
Performed [ftcn] 0.00169141433262
Heart [bpoc] 0.00168852192518
High Risk [qlco] 0.00166944644739
risk factors [qnco] 0.00164816429124
Hazard Ratio [qnco] 0.00163243367496
Statin [orch, phsu] 0.001623910495
Suggest [idcn] 0.00161544735557
Complications [patf] 0.00159671448722
Care [acty] 0.00158423780625
Radiation [npop] 0.00155905726804
IMPACT [gngm] 0.00154184282592
intervention [hlca] 0.00150808324929
Quality [qlco] 0.00150671236429
GY [geoa] 0.00150079295667
Evaluated [ftcn] 0.00149382927361
Objective [inpr] 0.00147158291494
Therapeutic [topp] 0.00141908712001
Identified [qlco] 0.00141215906652
Levels [qlco] 0.00140302493946
baseline [bodm] 0.00139725086415
Children [aggp] 0.00138338895482
Pulmonary Hypertension [dsyn] 0.00137736464591
Observed [ftcn] 0.00137661832151
Prevention [topp] 0.00137169140551
Improved [qlco] 0.0013706121057
Measured [qlco] 0.00136610087861
Evaluate [ftcn] 0.00134965771368
Needed [qlco] 0.00134737590527
Primary [qlco] 0.00132904813169
People [popg] 0.00132532718875
Venous malformation [anab] 0.00131916186328
Subject [grup] 0.00131745992499
symptoms [ftcn] 0.0013055839809
Cases [ftcn] 0.00128553568119
Prognostic Factor [clna] 0.00127619623887
Purpose [ftcn] 0.00127175827694
condition [dsyn] 0.00126952341405
cardiovascular events [fndg] 0.0012591735583
Assessed [acty] 0.0012572365456
Range [qnco] 0.00124785883999
Current [tmco] 0.00124444285784
Metabolic syndrome [dsyn] 0.00123850966561
Benefit [qnco] 0.00122465045829
Improvement [cnce] 0.00122268979046
Main [qlco] 0.00121453929304
Aged [orga] 0.00120753911716
Life [idcn] 0.00120037240681
considered [idcn] 0.00118162535266
Hormone replacement therapy [topp] 0.00117590040495
effective [qlco] 0.00117218471011
Published [ocac] 0.00117177796934
Score [qnco] 0.0011652118966
Need [qlco] 0.00116315653077
Blood Pressure [orgf] 0.00115460685208
Receive [qlco] 0.00115010150706
Heart failure [dsyn] 0.00114248129093
Diagnosed [fndg] 0.00113798961427
Events [evnt] 0.00113096536379
Design [acty] 0.00112783869716
Following [tmco] 0.0011277471295
Drug [phsu] 0.00110477824933
Statins [orch, phsu] 0.00109982359883
national [inpr] 0.00108639526501
Myocardial Infarction [dsyn] 0.00107575905582
System [ftcn] 0.00107389159021
search [inpr] 0.00107365061816
Irradiation [npop] 0.00105645819062
Article [inpr] 0.00105591157824
Controlled [ftcn] 0.00105510071302
Guidelines [inpr] 0.00104807641115
Diseases [dsyn] 0.00104544023763
Sclerotherapy [topp] 0.00103385150892
Severe [qlco] 0.00102514014176
interventions [hlca] 0.00102129489682
Received [qlco] 0.00101797638263
Available [ftcn] 0.00100928604445
Decreased [qnco] 0.000996039751453
reduction [npop] 0.000991467804816
Safety [hcpp] 0.000986172641481
Index [inpr] 0.000975828538833
Increasing [ftcn] 0.00097316258853
practice [menp] 0.000973161526169
Response [orga] 0.000964722305814
Obesity [dsyn] 0.000964516996812
Tool [mnob] 0.000961736728246
vascular [bpoc] 0.000959569829972
findings [ftcn] 0.000950712562045
Large [qnco] 0.000947638015572
Various [irda] 0.000947201331449
Well [qlco] 0.000942078856439
Cardiology [bmod] 0.000940399566757
Estimated [qnco] 0.000938990940153
randomized [resa] 0.000930394117729
Relationship [qlco] 0.000928536828608
Drugs [phsu] 0.00092812226141
Make [ftcn] 0.000927621344715
Several [qnco] 0.000922996425111
activity [dora] 0.00092241347679
postmenopausal [tmco] 0.000917651841074
placebo [topp] 0.000916576376935
Atrial Fibrillation [patf] 0.000910919372926
Affect [menp] 0.000906249783555
Chemotherapy [topp] 0.00090606976757
Atherosclerosis [dsyn] 0.000901586874043
coronary artery disease [dsyn] 0.00089900233069
Drug Therapy [topp] 0.00089738522749
days [tmco] 0.00089685755759
Five [qnco] 0.000894074917225
Cost Effectiveness [qnco] 0.000889071316205
Medical [ftcn] 0.000888237558739
Approach [spco] 0.000881287885577
Select [acty] 0.000880518495492
Decrease [qlco] 0.000878274095705
Comorbidities [idcn] 0.000870721717146
Hospital [hcro, mnob] 0.000863653796119
recommendations [idcn] 0.00085982844256
Characteristics [qlco] 0.000859097784998
coronary heart disease [dsyn] 0.000854787849827
Aspirin [orch, phsu] 0.000852174565457
Review, Systematic [inpr] 0.000846243610688
Adjusted [ftcn] 0.000843504383126
Hold [idcn] 0.000840974235661
Effectiveness [qlco] 0.000840939760987
Biomarkers [clna] 0.00083363804301
Body Mass Index [diap] 0.000827869193733
Imaging [diap] 0.000827224041471
Inspiration [orgf] 0.000823604616606
Breast [bpoc] 0.000822946231404
strategies [menp] 0.000822732742639
Functional [ftcn] 0.000821475433833
function [phsf] 0.000820379600355
patient care [hlca] 0.000818855299207
Combined [qlco] 0.000818218275772
radiation therapy [inpr] 0.000817377908932
PREVENT [phsu] 0.000816534435371
Lipid [lipd] 0.000814429625022
acute [tmco] 0.000811698028725
free [ftcn] 0.00080335463266
Known [qlco] 0.000800299323922
Adults [aggp] 0.000796957982249
Profile [lbpr] 0.000796539069731
investigate [ftcn] 0.000789597709353
Ratio [qnco] 0.00078824014987
Conduct [inbe] 0.000784655130917
Confidence Intervals [qnco] 0.00078213248113
Smoking [inbe] 0.000780304051097
Oral [spco] 0.000774599362586
Adult [aggp] 0.000772354473237
investigated [ftcn] 0.000770614201913
Parameters [fndg] 0.00076860212696
Complex [qlco] 0.000768589094498
Alone [qnco] 0.000766993785927
Searched [acty] 0.000766633128633
Moderate [qlco] 0.000766518034202
Diet [food] 0.000765740535384
C-reactive protein [aapp, imft] 0.00076340380151
Comparison [acty] 0.00076151267411
Information [idcn] 0.000761107150466
Support [medd] 0.000755777009503
Cardiovascular Diseases [dsyn] 0.000751457417572
Morbidity [qnco] 0.000748613961249
Appropriate [qlco] 0.00074785908607
Young [tmco] 0.000744125900813
Independent [idcn] 0.000743920675376
Long [qlco] 0.000742865357422
Androgen Deprivation Therapy [topp] 0.000742618794964
Prostate Cancer [neop] 0.000740083487433
Limited [ftcn] 0.00073915190411
Congenital heart disease [cgab, dsyn] 0.000738872307149
Often [tmco] 0.000738629152839
strategy [menp] 0.000735599684193
Obtained [ftcn] 0.000730490633895
Dyslipidaemia [dsyn] 0.000728205156014
Mechanisms [ftcn] 0.000728003408608
setting [ftcn] 0.000724508496458
Literature [inpr] 0.000723465074467
Stage [tmco] 0.000718442621372
Bleeding [patf] 0.000718122719008
lesions [fndg] 0.000716807830111
Medications [phsu] 0.000716415324535
Diabetes Mellitus [dsyn] 0.000715690103637
Discharge [bdsu] 0.000714814462256
Single [popg] 0.00071342360698
Acute Coronary Syndrome [dsyn] 0.000710802555609
Life Style [socb] 0.000709785775721
Represent [acty] 0.000708516100131
ischaemic heart disease [dsyn] 0.000707673397151
Surgical [hlca] 0.000702614095906
Average [qnco] 0.000702545395912
Evaluation [ftcn] 0.00069634453385
secondary [neop] 0.000694999760173
adverse events [fndg] 0.000693998955188
Multiple [qnco] 0.000692759420713
Future [tmco] 0.000692497060199
Guide [prog] 0.000692071300292
Physical activity [dora] 0.000691642772977
GIVEN [cnce] 0.000690977131296
Menopause [phsf] 0.000689131387707
LTD [ortf] 0.000688658863943
objectives [inpr] 0.000684279767192
experience [menp] 0.000678251164324
Part [spco] 0.000677637311673
Relevant [qlco] 0.000672821085077
Heart disease [dsyn] 0.000672182693526
Recommended [idcn] 0.000667037582831
Screening [hlca] 0.000666914952375
deep breath [sosy] 0.000665244262113
Authors [prog] 0.000662782090047
Values [qlco] 0.000660722992009
Hormone Therapy [topp] 0.000655019566511
Sex [orgf] 0.000649632664261
Exercise [dora] 0.000649407429934
APPEAR [qlco] 0.000648975928152
Occurred [acty] 0.000648664309119
Defined [cnce] 0.000646553247594
Medication [phsu] 0.000645842879054
Work [ocac] 0.000640297720358
Revealed [qlco] 0.000635746414209
weeks [tmco] 0.000634633141332
prescribed [hlca] 0.000631863906345
Normal [qlco] 0.000629163664633
Small [qnco] 0.000629096149477
Duration [tmco] 0.000628349595672
atorvastatin [orch, phsu] 0.000628041999618
Risks [qlco] 0.000627803950681
Ageing [orgf] 0.000625466912973
Program [cnce] 0.000624676478932
Six [qnco] 0.000624218224048
criteria [inpr] 0.000623877731184
Models [inpr] 0.000623685103269
Examined [fndg] 0.000623023913573
Survivors [podg] 0.00062197776216
prognostic [inpr] 0.000621426570406
In [qnco] 0.000618019529238
Established [qlco] 0.000616301805366
Estrogen [horm, phsu, strd] 0.000611803765939
Associations [menp] 0.00061133227362
Value [qnco] 0.000604389548679
Plasma [bdsu] 0.000604306466561
Optimal [qlco] 0.000602324273159
chronic [tmco] 0.000601987748506
Cholesterol [bacs, strd] 0.000597906372899
Leading [tmco] 0.00059650034726
reviewed [inpr] 0.000594583100367
Postoperative [tmco] 0.000593209114163
Treatments [topp] 0.000593165266445
randomized controlled trials [inpr, resa] 0.000591282609273
Addition [ftcn] 0.000590779620747
Address [inpr] 0.000590563164831
Combination [qlco] 0.000590476708844
retrospective [resa] 0.000589685651012
prospective [resa] 0.000587725500275
Assessment [hlca] 0.00058541347304
Inflammation [patf] 0.000584573441221
Burden [idcn] 0.000583536094726
Female [fndg] 0.000582719597415
Take [hlca] 0.000582532235843
Currently [tmco] 0.000581912926475
Bias [idcn] 0.000579904263533
Adherence [ftcn] 0.0005781285335
Collected [idcn] 0.000578029591037
Link [inpr] 0.000576435765909
Previous [tmco] 0.00057606123152
Issue [fndg] 0.000574736810376
Update [tmco] 0.000574082557766
Database [inpr] 0.000573866785161
cardiovascular risk factor [dsyn] 0.00057276268813
Lung [bpoc] 0.000570978196545
heart rate [clna] 0.000570560706481
Gender [orga] 0.000568121650366
Hospitalization [hlca] 0.000567472914414
mmHg [qnco] 0.000563817658098
variables [qlco] 0.000562062011768
Primary Care [hlca] 0.000560979495728
Report [inpr] 0.000560963421984
Understanding [menp] 0.000556839280478
Novel [tmco] 0.000554797184241
Knowledge [inpr] 0.000554241260615
Human [humn] 0.000553991184484
???lead [elii, hops] 0.000553164902504
left sided [spco] 0.000552050488279
Likely [qlco] 0.000551377994715
Marker [clna] 0.000551128408506
paediatric [bmod] 0.000550455374052
Last [qlco] 0.000549834455409
Diagnostic [fndg] 0.000549012635254
Age-Years [tmco] 0.000548029847233
Calculated [ftcn] 0.000547838294198
Reducing [qlco] 0.000547750619099
Questionnaire [inpr] 0.000547636109155
Concern [idcn] 0.000546061210034
Additional [ftcn] 0.000546024539953
Physicians [prog] 0.000544466248792
Length [qnco] 0.000544178448027
Improving [qlco] 0.000537221802141
Center [spco] 0.000535202298489
Late [tmco] 0.000533984483928
Vascular Malformations [anab] 0.000533708316713
Countries [geoa] 0.000533188802105
Measure [qnco] 0.00053140789094
Polypharmacy [fndg] 0.000530153969906
society [orgt] 0.000528730176449
Prescription [hlca] 0.000527765103017
Chronic kidney disease [dsyn] 0.000521841891555
Local [spco] 0.000519372927197
Derived [qlco] 0.000517873218623
side effects [ftcn] 0.000515707523943
techniques [inpr] 0.000513880404888
Benefits [qnco] 0.000513131872785
pulmonary [bpoc] 0.000512495754166
Scale [medd] 0.000511623880834
Few [qnco] 0.000510975977237
Continuous Positive Airway Pressure [topp] 0.000508650363804
Contribute [acty] 0.000508610006222
Blood [tisu] 0.00050857674456
Best [qlco] 0.000503724885003
Concentrations [menp] 0.000503689520266
Ischaemic stroke [dsyn] 0.000503569487227
Catheter Ablation [topp] 0.000503225422268
Observational Study [resa] 0.000500703316182
Correlation [qlco] 0.000500208462001
Agent [chvf] 0.000499108908746
Elderly [popg] 0.000498279922897
Dependent [qlco] 0.0004979293376
Help [socb] 0.00049753934938
Provided [acty] 0.000496351100718
Relative [famg] 0.000496311740902
History [ocdi] 0.000495795850978
Pre-operative [tmco] 0.000494972283571
Chronic disease [dsyn] 0.000491574447379
Procedure [diap, topp] 0.000489376282211
Meta-Analysis [inpr] 0.000487764319939
mice [mamm] 0.000485897895506
atherosclerotic [ftcn] 0.00048568496768
Test [lbpr] 0.0004848604378
coronary [bpoc] 0.000484444327718
Risk Ratio [qnco] 0.000481029669556
High dose [qnco] 0.000477673930311
Point [qnco] 0.000476040875749
Involving [ftcn] 0.000475840459008
Required [ftcn] 0.000474986052244
Advanced [qlco] 0.000471813439244
Technique [ftcn] 0.000471289479301
High sensitivity [lbpr] 0.000468578952895
procedures [inpr] 0.000466521100334
Registry [inpr] 0.000465450393287
Flow [npop] 0.000464484054932
Echocardiography [diap] 0.000464241903494
Frequently [tmco] 0.000463417877252
Central [spco] 0.000462400523899
Died [orgf] 0.000461761889716
Pulmonary arterial hypertension [dsyn] 0.000461696833068
Elevated [qlco] 0.000459951438462
Prediction [idcn] 0.000457912886088
